in re: healthsouth corporation 2002 securities litigation 02
TRANSCRIPT
IN THE UNITED STATES DISTRICT COURT F ! .,~ E WJFOR THE NORTHERN DISTRICT OF ALABAM A
SOUTHERN DIVISION 03 MAR 12 PM 3` 3 6
U.S . Di Ft RIOT COURTConsolidated Fil4' J
In re HEALTHSOUTH CV-02-BE-2105- S
CORPORATION 2002 SECURITIES
LITIGATION
This Document Relates To :
All Actions
CONSOLIDATED CLASS ACTION
COMPLAINT FOR VIOLATION OF
THE FEDERAL SECURITIES LAWS
JURY TRIAL DEMANDED
This Consolidated Class Action Complaint supersedes each o f
the complaints filed in the actions listed on Schedule 1 hereto .
Plaintiffs, individually and on behalf of others similarly
situated, by and through their attorneys, allege the following
upon information and belief, except as to those allegations
concerning Plaintiffs, which are alleged upon personal knowledge .
Plaintiffs' information and belief is based upon, among other
things, their counsel's investigation, which includes : (a) review
and analysis of filings made by HealthSouth Corporation
("HealthSouth" or the "Company") with the United States
Securities and Exchange Commission (the "SEC") ; (b) review and
analysis of securities analysts' reports concerning HealthSouth ;
(c) review and analysis of press releases and other
pronouncements by or on behalf of HealthSouth ; (d) review of
other publicly available information concerning HealthSouth
including transcripts of interviews with certain of the
Defendants ; (e) review of information obtained by private
investigators retained by counsel ; (f) information received from
1730 / CMP / 00060147 .WPD v1
qa
former employees of HealthSouth ; and (g) information obtained
from qui tam actions that have been filed against the Company .
SUMMARY OF THE ACTION
1 . This class action is brought under the federal
securities laws on behalf, of purchasers of HealthSouth common
stock on the open market from December 12, 2001 through August
26, 2002 (the "Class Period") . As a leading provider of
outpatient physical and rehabilitation therapy in the United
States, HealthSouth is required to comply with Federal
regulations governing billing for services to patients covered by
Medicare and other Government reimbursement programs . For many
years, the Government has had separate billing procedures and
codes distinguishing between individual and group therapy
sessions, with decidedly higher rates of reimbursement being paid
for individual rather than group therapy sessions .
2 . In order to artificially inflate the reported revenues
and profits of HealthSouth, Defendants caused the Company's
employees to systematically overcharge the Government by, among
other wrongful acts, "upcoding" the billing for group therapy
sessions as individual sessions . Indeed, the Company's billing
system did not even enable HealthSouth's employees to record
charges for group (as opposed to individual) therapy sessions .
Defendants then compounded that wrongdoing by, among other acts
of deception, repeatedly making inflated estimates of the
Company's revenues and earnings for 2002 ; and having Defendant
1730 / CMP / 00060147.WPD V1 2
Richard Scrushy ("Scrushy"), Chairman and Chief Executive
Officer, represent that the Company's shares should be "north of
$20 a share right now" (at a time when the shares were trading in
the $15 per share range) based on the Company's "growth rate" and
"strong cash flow ." As demonstrated herein, the numerous
material misrepresentations and materially incomplete statements
disseminated by Defendants caused an artificial inflation in the
market price of HealthSouth shares and enabled Defendant Scrushy
and other senior executives of the Company to sell more than $100
million in HealthSouth shares at inflated prices during the Class
Period .
3 . Offended by Defendants' wrongful conduct, HealthSout h
supervisory employees repeatedly complained to their colleagues
and superiors that they were being "stonewalled" in attempting to
obtain correct billing guidance ; compelled to participate in a
Medicare fraud ; and being put at risk of disciplinary or other
action by the Government . Those complaints were ignored by
HealthSouth and its senior executives .
4 . The fraud began to unravel in early 2002 when the
United States Department of Justice intervened as a named
plaintiff in several qui tam actions filed by former patients
charging the Company with billing fraud . Then on May 17, 2002,
the Centers for Medicare and Medicaid Services ("CMS") issued
regulations reaffirming that group therapy sessions are to be
billed as such, not as individual sessions . Throughout this
period, the Company did not curb its wrongful practices or
1730 / CMP / 00060147 .WPD v1 3
publicly disclose that its revenue, earnings and stock price
projections were grossly overstated .
5 . On August 27, 2002, the Company issued a press release
withdrawing its previous earnings guidance for 2002 and belatedly
disclosing that the Company's annualized earnings would b e
reduced by approximately $175 million as a result of the
Company's failure to comply with the Government's billing
regulations . Investor reaction was swift and negative . The
price of HealthSouth shares plunged nearly 60% on August 27 and
28, 2002, causing damages aggregating hundreds of millions of
dollars to Plaintiffs and the other members of the Class .
JURISDICTION AND VENUE
6 . The claims asserted herein arise under and pursuant t o
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934
(the "Exchange Act"), 15 U .S .C . §§ 78j(b) and 78t(a), and Rule
lob-5 promulgated thereunder by the Securities and Exchange
Commission ("SEC"), 17 C .F .R . § 240 .10b-5 .
7 . This Court has jurisdiction over the subject matter of
this action pursuant to 28 U .S .C . §§ 1331, and Section 27 of the
Exchange Act, 15 U .S .C . § 78aa .
8 . Venue is proper in this District pursuant to Section 27
of the Exchange Act and 28 U .S .C . § 1391(b) .
9 . In connection with the acts and omissions alleged in
this Complaint, Defendants, directly or indirectly, used the
means and instrumentalities of interstate commerce, including ,
1730 / CMP / 00060147 .WPD v1 4
but not limited to, the mails, interstate telephone
communications, and the facilities of the national securities
markets .
PARTIES
Plaintiffs
10 . By Order dated December 12, 2002, the Court appointe d
the "Federated Funds," consisting of the Federated Capital
Appreciation Fund, Federated Growth Strategies Fund, Federated
Capital Appreciation 2 Fund, Federated Growth Strategies 2 Fund,
Federated Stock & Bond Fund and the Federated Kaufmann Fund as
Lead Plaintiffs . The Federated Funds are registered investment
companies . As set forth in the certifications attached to the
Motion for Appointment as Lead Plaintiffs and Lead Counsel, and
incorporated herein by reference, the Federated Funds purchased
shares of HealthSouth common stock during the Class Period an d
were damaged thereby .
11 . The persons and entities listed on Schedule 2 annexed
hereto are additional plaintiffs in this action . During the
Class Period, each purchased shares of HealthSouth common stock
as specified in their respective certifications previously filed
with the Court, and were damaged thereby .
1730 / CMP 100060147 .WP1v1 5
Defendants
12 . (a) Defendant HealthSouth represents that it is the
nation's largest provider of outpatient surgery and
rehabilitative healthcare services . It provides such services
through its national network of outpatient and inpatient
rehabilitation facilities, outpatient surgery centers, diagnostic
centers, medical centers and other healthcare facilities . The
Company operates patient care locations throughout the United
States . HealthSouth maintains its principal executive offices at
One HealthSouth Parkway, Birmingham, Alabama 35243 .
(b) At all relevant times, HealthSouth derived a
material portion of its revenues and profits from Medicare and
other Government reimbursement programs . For example,
HealthSouth represented in a Report on SEC Form 10-K for the year
ended December 31, 2001 (the "2001 Form 10-K") that the Company
had derived 31% of its revenues from Medicare .
(c) At all relevant times, the Company had more than
390,000,000 shares of common stock issued and outstanding which
were listed and traded on the New York Stock Exchange (the
"NYSE") under the ticker symbol "HRC . "
13 . Defendant Scrushy is the founder of HealthSouth and
was, at all relevant times, Chairman, Chief Executive Officer,
and a Director of the Company . As detailed herein, during the
Class Period, Defendant Scrushy was the Company's principal
spokesman and made many of the false and misleading statements
issued by Defendants . Additionally, he sold or disposed of more
1730 / CMP / 00060147.WPD v1 6
than 7,700,000 shares of HealthSouth common stock for more than
$99,000,000, knowing of undisclosed material information
concerning the Company's business and operations .
14 . Defendant William Owens ("Owens") at all relevant time s
was the President and Chief Operating Officer of HealthSouth .
Owens has been a director of the Company since 2001 . As detailed
herein, Owens was integrally involved in making the materially
false and misleading statements to HealthSouth investors during
the Class Period . He signed the 2001 Form 10-K and was a
spokesman at Company presentations to analysts and investors and
a participant in conference calls with investors and analysts
during which many of the misrepresentations were made .
15 . Defendant Weston L . Smith ("Smith") was at all relevant
times the Executive Vice President and Chief Financial Officer of
HealthSouth . He also was integrally involved in the wrongdoing .
As Chief Financial Officer, Smith signed SEC filings containing
materially false and misleading statements and participated in
the quarterly conference calls with investors during which
numerous of the misrepresentations were made .
16 . Scrushy, Owens, and Smith are collectively referred to
as the "Individual Defendants . "
17 . (a) The Individual Defendants were the Company's
principal officers and controlled HealthSouth and its public
disclosures . Each of them made false and misleading statements
and/or failed to disclose material adverse information concerning
the Company's business and operations during the Class Period, as
1730 / CMP / 00060147.WPD v1 7
detailed herein . Because of the Individual Defendants' senior
executive positions with the Company, they had access to the
adverse undisclosed information about its business, operations,
operational trends, financial statements, and present and future
business prospects through access to internal corporate documents
(including the Company's operating plans, budgets, and forecasts
and reports of actual operations compared thereto), conversations
and connections with other corporate officers and employees,
attendance at management and/or Board of Directors meetings and
committees thereof, and via reports and other information
provided to them in connection therewith .
(b) In this regard, weekly 'Senior Management
Meetings" were held on Monday mornings at the Company's corporate
headquarters . Defendant Scrushy and/or Owens would preside at
those meetings, with Defendant Smith regularly in attendance on
behalf of the Finance Department . At the Senior Management
Meetings, the Individual Defendants received reports from
HealthSouth financial, regulatory and operational Department
heads on developments within their departments and matters of a
material nature that had arisen . As a result of these weekly
meetings and the numerous other communications to which the
Individual Defendants were privy, each of the Individual
Defendants was fully familiar with the status of HealthSouth's
regulatory, financial and business affairs .
18 . It is appropriate to treat the Individual Defendants as
a group for pleading purposes and to presume that the false ,
1730 / CMP / 00060147 .WPD v1 8
misleading, and incomplete information conveyed in the Company's
public filings, press releases, interviews, and other statements,
as alleged herein, were the collective actions of the thre e
Individual Defendants . Each of those officers and/or directors
of HealthSouth, by virtue of his high-level positions with the
Company, directly participated in the management of the Company,
was directly involved in the day-to-day operations of the Company
at the highest levels, and was privy to confidential proprietary
information concerning the Company and its business, operations,
growth, financial statements, and financial condition, as alleged
herein . Said Defendants knowingly or recklessly made the
materially false and misleading statements alleged herein ; were
involved in drafting, producing, reviewing and/or disseminating
the statements ; or approved or ratified the statements, in
violation of the federal securities laws .
19 . As officers and/or directors and controlling persons o f
a publicly held corporation whose common stock was, and is,
registered with the SEC pursuant to the Exchange Act, traded on
the NYSE, and governed by the provisions of the federal
securities laws, each of the Individual Defendants had a duty to
disseminate promptly accurate information with respect to the
Company's financial condition and performance , growth,
operations, financial statements , revenues , earnings , and present
and future business prospects , and to correct any previously
issued statements that were materially misleading or untrue, so
that the market price of HealthSouth common stock would be base d
1730 / CMP / 00060147 .WPD v1 9
upon truthful and accurate information . The Individual
Defendants' misrepresentations and materially incomplete
statements during the Class Period violated these specific
requirements and obligations .
20 . Because of their positions of control and authority a s
officers and/or directors of the Company, each of the Individual
Defendants was able to and did control the content of the various
SEC filings, press releases and other public statements issued by
or on behalf of the Company during the Class Period . Each
Individual Defendant was provided with copies of the documents
alleged herein to be misleading prior to or shortly after their
issuance and/or had the ability and/or opportunity to prevent
their issuance or cause them to be corrected . Accordingly, each
of the Individual Defendants is responsible for the accuracy of
the public reports and releases detailed herein and is therefore
primarily liable for the misrepresentations and materially
incomplete statements contained therein .
21 . Each of the Defendants is liable as a participant in a
wrongful scheme and course of business that operated as a fraud
or deceit on those who purchased or otherwise acquired
HealthSouth common stock during the Class Period by disseminating
materially false and misleading statements and/or concealing
material adverse facts . The scheme deceived the investing public
regarding HealthSouth's current and past business, operations,
and the intrinsic value of Company common stock ; caused
Plaintiffs and other members of the Class to purchase HealthSouth
1730 / CMP / 00060147 .WPD v1 10
common stock at artificially inflated prices ; and allowed
Defendant Scrushy and other corporate insiders to profit
personally from unlawful insider trading .
CLASS ACTION ALLEGATIONS
22 . Plaintiffs bring this as a class action pursuant to
Federal Rule of Civil Procedure 23(a) and (b)(3) on behalf of a
class (the "Class") consisting of all persons and entities who
purchased HealthSouth common stock on the open market during the
Class Period of December 12, 2001 through August 26, 2002, and
were damaged thereby . Excluded from the Class are Defendants ;
the officers and directors of the Company during the Class
Period; any entity in which any Defendant has or had a
controlling interest ; members of the immediate family of any
excluded person ; and the legal representatives, heirs, successors
or assigns of any such excluded person or entity .
23 . The members of the Class are so numerous that joinde r
of all Class members is impracticable . More than 480 million
shares of HealthSouth common stock were traded publicly on the
NYSE during the Class Period . While the exact number of Class
members is unknown to Plaintiffs at this time and can only be
ascertained through appropriate discovery, Plaintiffs believe
that there are many thousands of geographically dispersed members
of the proposed Class . Record owners and other members of the
Class may be identified from records maintained by HealthSouth or
its stock transfer agent and may be notified of the pendency of
1730 / CMP / 00060147 .WPD vl 11
this action by mail, using a form of notice similar to that
customarily used in securities class actions .
24 . Plaintiffs' claims are typical of the claims of the
members of the Class as all members were similarly affected by
Defendants' wrongful conduct in violation of federal law that is
complained of herein .
25 . Plaintiffs will fairly and adequately protect the
interests of the members of the Class . Plaintiffs have no
interests antagonistic to the interests of the Class and have
retained counsel competent and experienced in class and
securities litigation .
26 . Common questions of law and fact exist as to the
members of the Class and predominate over any questions affecting
individual members . Among the questions of law and fact common
to the Class are :
a . whether Defendants' acts and/or statements as
alleged herein violated the federal securities laws ;
b . whether Defendants' billing practices knowingly
violated Government rules and regulations ;
c . whether Defendants knowingly or recklessly
misrepresented and/or omitted material facts about the business,
operations and earnings of HealthSouth during the Class Period ;
d . whether the market price of HealthSouth shares was
artificially inflated during the Class Period ; and
e . whether the members of the Class have sustained
damages and the proper measure of damages .
1730 / CMP / 00060147 . WPD v1 12
27 . A class action is superior to all other available
methods for the fair and efficient adjudication of this
controversy . As the damages suffered by individual Class members
may be relatively small, the expense and burden of individual
litigation make it impossible for members of the Class
individually to redress the wrongs done to them . There will be
no difficulty in the management of this action as a class action .
ADDITIONAL SUBSTANTIVE ALLEGATIONS
Outpatient Billing Under Medicare
28 . Medicare is a federally funded program that provides
health insurance coverage for persons age 65 or older and for
some disabled persons . That program and the related Medicaid
program are administered by CMS .
29 . Providing therapeutic treatment to persons covered by
Medicare is an integral part of HealthSouth's business, and
generates a material portion of the Company's revenues and
earnings . HealthSouth has represented in its public filings that
approximately 30% of its revenues are derived from patients
covered by Medicare .
30 . In 1997, Congress passed the Balanced Budget Act of
1997 (the "BBA") which contained numerous changes to the way
Medicare reimbursed healthcare providers . Prior thereto,
healthcare providers were reimbursed by Medicare on a cost basis,
whereby interim estimated payments were made to providers an d
1730 / CMP / 00060147.WPD v1 13
reconciled by a cost report submitted at the end of a fiscal
year . After the enactment of the BBA, a prospective payment
system was gradually implemented, where reimbursement was made to
providers after services were provided and claims were submitted
to Medicare . Rules promulgated concerning Medicare are published
in the Medicare Manual, the Federal Register and also through
transmittals and program memoranda issued by CMS .
31 . CMS, through its predecessor, the Healthcare Financing
Administration ("HCFA"), developed a sophisticated coding system
known as HCFA Common Procedural Coding System ("HCPCS") to
reimburse physicians and other healthcare professionals for
services rendered .
32 . Effective January 1, 1999, all providers, includin g
outpatient physical therapy and speech pathology rehabilitation
agencies such as those owned and operated by HealthSouth, were to
be paid under HCPCS . The codes applicable to outpatient
rehabilitative therapy were developed by the American Medical
Association (the "AMA") Current Procedural Terminology Editorial
Panel . The codes are republished and updated annually by th e
33 . The codes are known as "CPT" codes and are set forth in
an annual compendium known as the AMA Current Procedural
Terminology publication (the "CPT Publication") . CPT codes are
nearly universally recognized and utilized by payers of health
claims across the nation . (In fact, even before January 1, 1999,
non-cost based providers -- including therapists in privat e
1730 / CMP / 00060147 .WPD v1 1 4
practice -- used the codes to bill Medicare for rehabilitation
services . )
34 . As explained in the CPT Publication : "The purpose of
the terminology is to provide a uniform language that will
accurately describe medical, surgical, and diagnostic services
and will thereby provide an effective means for reliable
nationwide communications among physicians, patients, and third
parties . "
35 . The CPT Publication contains a section entitled
"Physical Medicine and Rehabilitation" which is further
subdivided into two sections, "Modalities" and "Therapeutic
Procedures ." Therapeutic Procedures is defined as "a manner of
effecting change through the application of clinical skills
and/or services that attempt to improve function . The physician
or therapist is required to have direct (one on one) patient
contact . "
36 . Two primary CPT codes have been available since the
early 1990s for rehabilitative therapeutic procedures provided to
outpatients -- Code 97110 for "therapeutic exercise" and Code
97150 for "group therapeutic procedure . "
37 . Code 97110 pertains to one-on-one therapeuti c
procedures while 97150 pertains to group activities during which
constant attendance is required but one-on-one treatment is not .
Code 97110 is billable for every fifteen minutes of one-on-one
treatment whereas 97150 is not a timed code . Under CMS rules, a
1730 / CMP / 00060147.WPD vi 15
provider generally cannot bill for services within the same
session under both 97110 and 97150 .
38 . Each CPT code is assigned a value by CMS based on it s
own assessment and recommendation from the CPT Relative Value
Update Committee . The value for each CPT code is determined by
comparing the value of the resources needed to provide that
particular service to the value needed for other services .
39 . Group therapy has always been valued lower than
individual therapy because it requires less resources from a
therapist . In 2002, Medicare reimbursement for individual
physical therapy services under Code 97110 averaged $27 .51, which
can be billed per 15-minute interval, versus $18 .10 for group
therapy services under Code 97150 which cannot be billed in 15-
minute intervals .
The 1994 Codification of Individual and Group Billinc Codes
40 . On December 8, 1994, CPT codes 97150 and 97110 wer e
codified in the Federal Register, Vol . 61, No . 227 . Under that
regulation enacted by the HCFA, therapists "must bill" using the
group code -- 97150 -- for any therapy that is not provided on a
one-on-one basis :
. . . If the provider is overseeing the therapy
of more than one patient during a period of
time, he or she must bill the code for grouptherapy (CPT code 97150), since he or she isnot furnishing constant attendance to asingle patient .
1730 / CMP / 00060147 .WPD v1 16
The Repeated Reminders of the Distinction
Between Individual and Group Therapy Treatment
41 . The AMA publishes a monthly periodical entitled the
"CPT Assistant" which contains discussions of various codes and,
on occasion, sets forth questions and answers pertinent to a
code . The CPT Assistant is widely read by practitioners in the
healthcare industry, including executives at healthcare providers
such as HealthSouth . An issue of the CPT Assistant that was
disseminated during the Summer of 1995 contained the following
relevant explanation of the individual and group therapy codes at
issue :
Therapeutic Procedures
Therapeutic procedures are intended to be
performed with one-on-one patient contact .
If a provider is performing therapeutic
procedures in a group of two or more
individuals, only CPT code 97150 will bereported . Time and/or number of therapeutic
procedures is not defined in this code .
(Emphasis in original . )
42 . Further rules and regulations distinguishing individual
and group therapy billing procedures were enacted by the HCFA
published on November 22, 1996 in Vol . 61, No . 227 of the Federal
Register . Those regulations stated, in relevant part as follows :
We base the work [relative value units] forthese services on the expectation that the
definition of the codes represents how theservices will be furnished when billed toMedicare . For example, we expect that when
15 minutes of a service in the constant
attendance category is billed, we may beconfident that the provider furnished the 1 5
1730 / CMP / 00060147.WPD vl 17
minutes of constant one-on-one attendancethat is included in the definition of thecode . If the provider did not furnish 15minutes of one-on-one constant attendance, asthe code is defined, he or she may not bill acode for 15 minutes of constant attendance .If the provider is overseeing the therapy ofmore than one patient during a period oftime, he or she must bill the code for grouptherapy (CPT code 97150), since he or she isnot furnishing constant attendance to asingle patient .
(Emphasis added . )
43 . In the December 1996 issue of the CPT Assistant, th e
following question was raised concerning billing under the group
code and the following response was given :
Question
When reporting CPT code 97150, therapeutic
procedure(s), group (2 or more individuals),should another code(s) be reported in
addition to the group code to specify the
type of therapy ?
AMA Comment
Group therapeutic procedures include CPT
codes 97110-97139 . If any of these
procedures are performed with two or moreindividuals, then only report 97150 . Do not
code the specific type of therapy in addition
to the group therapy code .
44 . In the February 1997 edition of the CPT Assistant ,
healthcare providers were again reminded that group code 97150 i s
to be used if therapeutic procedures are performed with "2 or
more individuals" :
Question
When reporting CPT code 97150, therapeutic
procedure(s), group (2 or more individuals) ,
1730 / CMP / 00060147 .WPD v1 18
should another code(s) be reported in
addition to the group code to specify the
type of therapy ?
AMA Cozmneut
Group therapeutic procedures include CPT
codes 97110-97139 . If any of these
procedures are performed with two or more
individuals, then only report 97150 . Do notcode the specific type of therapy in addition
to the group therapy code .
45 . The CPT Publication for 1999 contained the followin g
descriptions for the 97110 and 97150 codes :
97110 Therapeutic procedure , one or more
areas , each 15 minutes ; therapeutic exercisesto develop strength and endurance, range of
motion and flexibility .
97150 Therapeutic procedure(s), group (2 or
more individuals . )
46 . The CPT Publications for 2000, 2001 and 2002 describ e
therapeutic exercise and group therapeutic procedures as follows :
97110 Therapeutic procedure, one or more
areas, each 15 minutes ; therapeutic exercises
to develop strength and endurance, range of
motion and flexibility .
97150 Therapeutic procedure(s), group (2 ormore individuals )
• (Report 97150 for each member of thegroup )
• (Group therapy procedures involve
constant attendance of the physician ortherapist : but by definition do notrequire one-on-one patient contact by
the physician or therapist . )
47 . In May 2000, HCFA issued Transmittal AB-00-39 which se t
forth the time parameters by which one could bill a single 15-
minute unit under code 97110 .
1730 / CMP / 00060147 . WPD v1 19
48 . An article concerning the appropriate procedure fo r
billing for group therapy was contained in the April 13, 2001
edition of Eli's Rehab Report, another widely read industry
publication . In that article, healthcare practitioners were told
the following :
HCFA also weighs in on group therapy in the
transmittal, stating that "we are concerned
that some providers may not be familiar withthe CPT definition" of group therapy . HCFA
explains that Code 97150 must be used when a
therapist performs "procedures with two or
more individuals concurrently or during thesame time period . "
HEALTHSOUTH EMPLOYEES REPEATEDLY QUESTION
THE COMPANY'S UPCODING AND BILLING PRACTICE S
49 . The foregoing CMS rules and regulations, CPT cod e
descriptions, and AMA and other industry pronouncements setting
forth the appropriate method for billing individual and group
therapy sessions caused numerous HealthSouth employees (now
former employees) who were integrally involved in the Company's
outpatient therapy operations as administrators, supervisors and
therapists repeatedly to question whether the Company was
systematically overbilling the Government by upcoding : improperly
billing group therapy sessions as individual sessions . These
employees further noted that HealthSouth's nationally used
billing program -- "HCAP Support Services" -- (HealthSouth
Clinical Automated Program Number 7) ("HCAP") did not even allow
coding for group therapy under CPT Code 97150 . Notwithstanding
1730 / CMP / 00060147 .WPD v1 2 0
these repeated communications on the matter to senior executives
at HealthSouth, the Company continued systemically to upcode and
overcharge the Government by, among other improper acts, billing
group therapy sessions as individual sessions .
Former Employee No . 1
50 . From July 1995 to December 2001, Former Employee No . 1
was a physical therapist and head administrator of a HealthSouth
rehabilitation clinic located in Indiana . In that capacity,
Former Employee No . 1 supervised eight other employees, including
three physical therapists and an occupational therapist .
51 . In the Spring of 2001, Former Employee No . 1 and other
employees at the HealthSouth facility read the article contained
in the April 13, 2001 edition of Eli's Rehab Report (see 9[ 48,
supra) concerning outpatient group therapy coding and also spoke
to other physical therapists with HealthSouth, including one
physical therapist whose billing practices had been audited .
Those communications confirmed that the Eli Rehab Report had
accurately described the Government's policy on coding for
outpatient individual and group physical therapy .
52 . Acting on his own initiative and at the urging o f
another colleague who was also concerned about the
appropriateness of HealthSouth's billing practices, on April 23,
2001, Former Employee No . 1 e-mailed his supervisor Bill Schmidt
("Schmidt") at HealthSouth's regional office in Indiana and Jon
A . Santini ("Santini"), a HealthSouth technical support executive
1730 / CMP / 00060147 .WPD vi 2 1
based in Ohio, seeking clarification of the appropriate billing
practices . Former Employee No . 1 also raised the matter with
Vicki Sherman ("Sherman"), a HealthSouth Regional Clinical
Director based in Ohio, who was visiting the facility .
53 . Former Employee No . 1 and his co-workers were extremely
concerned about this issue because treating two or more
individuals concurrently was "the rule more than the exception,"
and the HCAP billing program utilized at HealthSouth did not even
permit group billing under CPT Code 97150 . Former Employee No . 1
further noted in his April 23 e-mail to Messrs . Schmidt and
Santini that the Government "pays much less" for a group therapy
session .
54 . When a response was not forthcoming, Former Employee
No . 1 sent follow-up e-mails to his supervisor, Mr . Schmidt, and
other supervisors, seeking "Corporate input" on the matter . He
further stated in one of his e-mails sent on April 26, 2001 to
Mr . Schmidt ; Walt Jimenez ("Jimenez"), Schmidt's supervisor ; and
Ms . Sherman, "I certainly understand the huge financial
implications, but am not willing to jeopardize my license . "
55 . That afternoon, Mr . Santini communicated with David
McMullan ("McMullan"), a HCAP Support Services Manager based in
HealthSouth's headquarters in Birmingham, Alabama . In an e-mail
response to Mr . Santini, Mr . McMullan confirmed that the HCAP
billing system "does not support Group PT/OT," i .e ., permit entry
of a group billing code . Mr . McMullan further noted that if the
interpretation were accurate, "you could consider 75-80% of HS
1730 / CMP / 00060147 .WPD v1 22
patients treated in group " and that doing so would have
"significant impact financially to the clinic " and, of necessity,
to HealthSouth .
56 . On April 30, 2001, Former Employee No . 1 sent another
follow-up e-mail to Messrs . Jimenez and Schmidt when he still had
not received an acceptable response . in that e-mail message,
entitled "HCAP-HCFA Group Therapy," Former Employee No . 1
elaborated upon his reasons for believing the Company was
committing "Medicare billing fraud" :
As you know from last weeks e-mails I have
expressed a concern re : this issue . I am
still concerned . . . . I base my concerns notonly on the Eli Rehab Report article dated 4-
13-01, but I also have talked to another
Indiana P .T . who had an independent
compliance audit done for his practice . . . .[T]he auditor that visited my friend agreed
with what is reported in the Eli report . I
am not trying to create trouble and certainly
do understand the financial ramifications of
this, but one must also consider the
financial issues of a Medicare billing fraud
claim . In Orlando we repeatedly hear "do the
right thing" and listen to the compliance
attorneys [sic] presentations . I will feel
much more comfortable when someone is able to
actually produce this policy . Your response
to this will be appreciated .
(Emphasis added . )
57 . Dissatisfied with the lack of response from his
HealthSouth superiors, Former Employee No . 1 contacted the
American Physical Therapy Association ("APTA") for its
interpretation on group therapy billing . That organization
confirmed that the practices being employed by HealthSouth were
improper .
1730 / CMP / 00060147.WPD v1 2 3
58 . On May 2, 2001, Former Employee No . 1 then sent an
e-mail summarizing his discussions with the APTA to Schmidt . In
that e-mail, Former Employee No . 1 stated that he had been told
by APTA "that the group therapy code should be used whenever
treating two or more patients at the same time . She stated that
this has been a HCFA guideline dating back to 1996 . "
59 . On May 3, 2001, Former Employee No . 1 then received a
fax transmission from APTA explaining : "If you are treating two
patients at the same time you need to use group therapy code ."
That fax transmission enclosed the applicable page from the 1996
HCFA regulations (see % 42, supra) on which APTA based its
conclusion .
60 . The next day, Former Employee No . 1 forwarded the APTA
transmissions to his superiors, Mr . Schmidt and Ms . Sherman, and
reiterated his request for clarification concerning HealthSouth's
position on group therapy billing . Former Employee No . 1 wrote
as follows :
All I am asking for is to be advised inwriting or e-mail form what HS's position is
on this issue based upon the fact that I can
not bill for group therapy even if I want to .
61 . In response, Ms . Sherman sent an e-mail to Former
Employee No . 1, his superior (Mr . Schmidt) and seventeen other
HealthSouth executives, stating :
I wanted to let you all know that I will be
attending a training in Birmingham on May 7 .The focus of the training will be on the HCAR
Audit (Medicare) and the new Outpatient P&PManual .
1730 / CMP 100060147 .WPD v1 2 4
After I return from the training, I will sendout information to each of you (or schedule aconference call) on both the HCAR audit andthe new P&P manual .
While I'm in Birmingham, I will also try toobtain information on Medicare billingissues, especially regarding the use of"group therapy" codes .
62 . On May 9, 2001, Former Employee No . 1 was told by Ms .
Sherman that she had not obtained clarification of the group
billing issue from HealthSouth's senior management while in
Birmingham . She further told Former Employee No . 1 that
HealthSouth was continuing to have its employees (impermissibly)
bill group therapy sessions as if they were one-on-one sessions .
In an e-mail to Schmidt that afternoon, Former Employee No . 1
repeated Ms . Sherman's remarks and stated : "Scares me . Advise .,,
63 . Still unable to obtain a response, on May 10, 200 1
Former Employee No . 1 sent an e-mail re : "Stonewalled on group
therapy" to Messrs . Santini, Jimenez, and Jimenez's superior,
Floyd Stahl ("Stahl") . In that e-mail, Former Employee No . 1
summarized his concerns that HealthSouth was perpetrating
"billing fraud" :
As most of you know I have been repeatedlyexpressing my concerns re : group therapy
billing dating back to 4-23-01 . I know andrealize that this is a very controversial
issue and is open to many differentinterpretations . What concerns me is that
many people and organizations (HCFA & APTA)state that when treating two or more people
at the same time you must bill as group
1730 / CMP / 00060147 .WPD v1 25
therapy . I have the HCFA transmittal, a tape
recorded message from Elizabeth O'Brien from
the APTA Department of Governmental Affairs,and a copy of the HCFA Federal Register all
backing-up this interpretation . I have been
advised that HS has a policy on this, but allefforts on my part to obtain a copy of this
have been unsuccessful . As you should knowthere is no way for us to bill for group
therapy in the HCAP system even if we wanted
to . The fact that we are being asked to
continue billing with this system, knowingthat some people may interpret this asbilling fraud causes me significant
concern . . . .
(Emphasis added . )
64 . On may 14, 2001, the "Stonewalled on group therapy "
e-mail message was sent by Mr . Santini to Mike McCracken
("McCracken") in HealthSouth's corporate headquarters . Mr .
Santini requested clarification of the "Group Therapy issue" in
an effort to "resolve the problems and put everyone's minds at
ease ."
65 . On May 15, 2001, Mr . Schmidt provided Former Employe e
No . 1, Mr . Jimenez and Ms . Sherman with a document entitled
"Position on Group Therapy" which purported to set forth
Schmidt's understanding of HealthSouth's position on group
therapy billing :
It is the position of HealthSouth that simplybecause two patients are being treated during
the same period, this does not necessarilyconstitute group therapy and, as such,
patients will continue to be charged forindividual therapy sessions . A group therapy
charge would only be appropriate in caseswhere two or more patients are being treated
during the same time period for the samediagnosis and with the same modality or
treatment .
1730 / CMP / 00060147 .WPD v1 2 6
Notably, this interpretation is inconsistent with the plai n
language of the existing CPT codes and interpretative literature ,
as set forth in paragraphs 31-48, supra .
66 . Ms . Sherman then sent an e-mail later that day to
Messrs . Schmidt, Jimenez, and Stahl, stating :
I have now talked to 6 people from corporatein the various departments of MedicareCertification, Medicare Reimbursement andQuality Standards . So far, I have not beentold that there is an "official corporatepolicy ." None of the people that I havetalked to have been able to give a definitiveanswer . . . .
67 . On May 17, 2001, Former Employee No . 1 sent Mr . Schmidt
a schedule summarizing 30 of the communications Former Employee
No . 1 had had with his superiors, colleagues, or APTA questioning
the appropriateness of HealthSouth's billing practices . In his
accompanying e-mail message to Mr . Schmidt, Former Employee No . 1
stated :
Enclosed please find my documentedcommunication efforts trying to resolve the
"group therapy" issue . I know management has
become irritated that I continue to pursuethis, but I feel my clinicians and myself
need to be assured that we are "doing the
right thing" . We are the one with a license,
career, and profession to protect and I donot feel my requests have been at all
unreasonable .
68 . On May 17, 2001, Mr . McCracken sent an e-mail message
to Messrs . Santini, McMullan and Former Employee No . 1
representing that the group therapy issue was "being worked on a t
a high level in HealthSouth" :
1730 / CMP / 00060147.WPD v1 2 7
From what I understand, HCAP does not allow
the therapist to bill group therapy .
Information received recently from APTAindicates that group therapy should be billed
for 2 or more individuals receiving
therapy . . . . This is being worked on at a
high level in HealthSouth, but it sounds like
you know as much as I do right now .
(Emphasis added . )
69 . On May 18, 2001, Former Employee No . 1 sent Mr . Santini
an e-mail thanking him for his assistance in having HealthSouth's
senior executives address the group billing issue . In that
e-mail, Former Employee No . 1 further expressed his awareness
that he had "ruffled a few feathers" at the Company by pressing
the fact that HealthSouth had been systematically overbilling the
Government by upcoding group therapy sessions to one-on-one
sessions for billing purposes and "need[ed] to back off" on the
matter .
70 . Nevertheless, on May 29, 2001, Former Employee No . 1
sent Mr . Santini an e-mail reopening the matter because of a
recently announced settlement with Medicare for "overbilling" :
I know I had vowed to back off on the "group"
controversy, but in view of last week'ssettlement with Medicare, for "overbilling"
would it not be advisable to get some
resolution on this ASAP? Just my views . . . .
71 . On May 31, 2001, Mr . Schmidt sent an e-mail to his
superiors, Messrs . Stahl and Jimenez, recommending that
HealthSouth address the overbilling issue :
I appreciate your recognition of the issue
. . . regarding how HCAP does (or does not)address group therapy charges . While we seem
to have reached consensus conceptually on
1730 / CMP / 00060147.WPD v1 2 8
this matter, I think we still need to look atthis matter on a global level as there hasnever been clear resolution provided byanyone at the corporate level .
This recommendation was ignored too and HealthSouth continued t o
stonewall and systematically overbill the Government on group
therapy sessions .
Former Employee No . 2
72 . Former Employee No . 2 worked for HealthSouth as a
Supervisor for Registration at a HealthSouth clinic in New Jersey
for about three years until her departure on or about October 1,
2001 . Former Employee No . 2 also witnessed rampant upcoding by
the HealthSouth employees at the clinic . Again, group physical
therapy sessions were improperly upcoded and charged to Medicare
as if the sessions had involved individual treatment . Former
Employee No . 2 witnessed these practices throughout her career at
HealthSouth .
73 . Moreover, there were other upcoding practices at th e
HealthSouth clinic which were even more egregious . For example,
a HealthSouth employee who lacked any "formal training," and was
not a physical, occupational or speech therapist, was designated
as a "job coach ." He would work with 7 or 8 patients and do
practically nothing -- perhaps discuss employment opportunities,
perhaps do a few exercises , and would bill for each patient as if
individual therapy had been performed .
1730 / CMP / 00060147 .WPD v1 2 9
Former Employee No . 3
74 . Former Employee No . 3 was a HealthSouth Director of
Business Development at a hospital in Florida from mid-1999 to
late 2000 . In that capacity, Former Employee No . 3 supervised
4-6 employees . Her duties included supervising the admissions
department and in-patient and out-patient business development .
After leaving HealthSouth, Former Employee No . 3 remained in
contact with former colleagues at HealthSouth facilities . From
those colleagues she learned that questions arose as to whethe r
HealthSouth was improperly billing group therapy sessions as
individual sessions . Specifically, colleagues of Employee No . 3
asked management at HealthSouth's corporate headquarters for
guidance as to whether the facility was correctly billing as
individual sessions therapy that should be billed under the group
CPT Code . Instead of providing its employees with guidance on
the matter, HealthSouth's executives at corporate headquarters
advised Former Employee No . 3's colleagues to continue billing
their activities as individual rather than group therapy
sessions .
Former Enwloyee No . 4
75 . Former Employee No . 4 was employed as a Prospective
Payment Systems Specialist at a HealthSouth rehabilitation
hospital in Las Vegas, Nevada for about six months until her
departure in June 2002 . During her employment, Former Employee
No . 4 was aware of practices by the Company to manipulate billin g
1730 / CMP / 00060147.WPD v1 30
codes under PPS to boost revenues . Specifically, Former Employee
No . 4 was pressured by her supervisors to "move up" the codes,
i .e ., bill a code that earns a higher rate, to obtain a higher
reimbursement from Medicare .
THE QUI TAM ACTIONS
76 . In addition to the questionable billing practices
raised internally by HealthSouth's employees, over at least the
past five years, the Company has been a defendant in at least
four gui tam actions alleging that HealthSouth had improperly
overcharged Medicare for therapy services provided to patients at
the Company's facilities . Those actions are as follows :
The Devace Action
77 . On April 24, 1998, James Devage, a former HealthSouth
patient, filed an action (the "Devage Comp .") in the United
States District Court for the Western District of Texas, San
Antonio Division, U.S . ex rel Devage v. HealthSouth Corp . et al .,
Civil Action No . SA-98-CA-0372 (DWS) (the "Devage Action") .
78 . In the Devage Action, Plaintiff alleged, among other
unlawful acts, that HealthSouth knowingly and fraudulently
overcharged Medicare for :
• individual therapy sessions that were in
fact group therapy, under the pertinentbilling codes and procedures ; DevageComp . 19[ 49, 50 .
1730 / CMP / 00060147.WPD v1 31
• therapeutic exercises (gym) to develop
strength and endurance, range of motion,and flexibility with direct (one-on-one)
contact between the patient and the
therapist when in fact, one-on-one
services were never performed ; DevageComp . 1 56 .
• aquatic therapy with therapeutic
exercises with direct contact when infact one-on-one services were not
performed and/or where the service was
not medically necessary . Devage Comp .1 62 .
79 . Mr . Devage further alleged that after demonstratin g
exercises to new patients on an individual basis, and thereafter
not providing one-on-one contact except to answer occasional
questions as set forth in Devage Comp . 11 57-58, the physical
therapists would nevertheless bill for individual therapy .
80 . According to Mr . Devage, HealthSouth als o
misrepresented to Medicare the location where the outpatient
therapeutic services had been performed in order improperly to
receive the higher reimbursement rates allowed in certain
geographic areas . Devage alleged that he had received his
physical therapy in San Antonio, Texas, but his Medicare
explanation of benefits indicated that he had received the
therapy in Austin, Texas, where Medicare reimbursement rates are
higher . Devage Comp . 1% 67-68 .
81 . All of the above allegations were based on either
Devage's personal knowledge or communications with fellow
patients who confirmed that they had had similar experiences .
Devage Comp . ¶j 13, 65 .
1730 / CMP / 00060147 . WPD vl 32
82 . In May of 2002, the United States intervened in the
Devage Action as a plaintiff . The Government complaint (the
"U .S . Comp .") alleged that between January 1, 1996 and May 23,
2002, the date of the filing of the Government complaint ,
HealthSouth improperly submitted claims to Government payors for
therapy services provided at outpatient physical therapy
facilities without a properly certified plan of care, as required
by Medicare regulations .!/ The Government further alleged that
HealthSouth improperly billed Government payors for services not
provided or for services provided by unqualified personnel . Id .
83 . Since early 1995, the Cahaba Government Benefit s
Administration, a division of Blue Cross Blue Shield of Alabama
("Cahaba") has served as national fiscal intermediary/carrier for
HealthSouth . U .S . Comp . 1 15 . In this capacity, Cahaba
processed most Medicare claims submitted by HealthSouth . Id . In
1996 and 1997, during a routine analysis of outpatient claims,
Cahaba noticed certain aberrations in claims that HealthSouth had
submitted . U .S . Comp . 1 16 . Accordingly, Cahaba began a full
investigation of HealthSouth's Medicare billing practices . id .
84 . According to the Government, the Cahaba investigation
included a review of more than 5,000 Medicare claims for services
1 A plan of care is required by law before a therapy
provider can be reimbursed by Medicare . The plan, required by 42U .S .C . § 1395 must be prepared by a physician or physicaltherapist . 42 C .F .R . § 410,61(b)(1) ; 42 C .F .R . § 485 .711 . It
must describe the type, amount, frequency and duration of thephysical therapy to be furnished to the patient, and must
indicate the diagnosis and anticipated goals . 42 C .F .R .§ 410,61(b)(1) ; 42 C .F .R . § 485 .711 .
1730 / CMP / 00060147 .WPD v1 33
rendered at 60 HealthSouth outpatient facilities . U .S . Comp .
1 17 . The consultants who reviewed the records found similar
instances of HealthSouth's failure to obtain properly certified
plans of care in connection with a substantial percentage of the
Medicare claims reviewed, including facilities where the failure
to comply with the plan of care requirements was nearly 100% .
U .S . Comp . 1 26 . In addition, Cahaba conducted pre-payment
audits of Medicare claims submitted by HealthSouth outpatient
physical therapy facilities during 1999 . Id . Those audits
revealed a similarly high claims denial rate based on
HealthSouth's failure to obtain a properly certified plan of care
for the physical therapy services rendered to the beneficiary .
Id . In fact, from January 1, 1996 until the date the Government
complaint was filed in May 2002, HealthSouth routinely sought
reimbursement for outpatient physical therapy services provided
in the absence of a certified or recertified plan of care .? /
U .S . Comp . ¶ 23 .
85 . The Government also charged HealthSouth with billin g
for services provided by unqualified personnel . For example, the
Medicare program only pays for outpatient physical therapy
services that are provided by qualified personnel . U .S . Comp .
1 30 . Specifically, personnel qualified to provide outpatient
physical therapy services are limited to licensed physica l
2 The Government alleged numerous specific examples,
provided by confidential sources, of HealthSouth's submission ofclaims to Medicare despite a failure to comply with the plan ofcare requirements . U .S . Comp . ¶ 25 a-d .
1730 / CMP / 00060147 .WPD v1 34
therapists and licensed physical therapy assistants who are
acting under the supervision of a licenced physical therapist .
Id . The Medicare program does not pay for physical therapy
services provided by supportive personnel, such as physical
therapy aides, athletic trainers or student trainees . U .S . Comp .
1 31 . Nevertheless, in an effort to boost its Medicare claims
and revenues, HealthSouth adopted and implemented a corporate
policy permitting and encouraging the use of supportive personnel
to provide physical therapy services to Medicare beneficiaries .
U .S . Comp . 1 32 . This policy was sometimes referred to as "Team
Treatment ." Id . Implementation of the "Team Treatment" policy
resulted in Medicare claims for reimbursement being
systematically submitted by HealthSouth facilities for physical
therapy services provided by supportive personnel . Id .
86 . On occasion, the "Team" would consist of a physical
therapy assistant and supportive personnel . U .S . Comp . ' 33 .
For each member of the "Team," two or more patients would be
given appointments to receive physical therapy at the same or at
an overlapping time . Id . HealthSouth submitted a claim for
reimbursement for the services provided to the patient
notwithstanding the fact that the patient was treated by
supportive personnel rather than a physical therapist or physical
therapy assistant . Id . Also, the services provided to each
patient were billed as if the physical therapist or physical
therapy assistant provided direct, one-on-one care . U .S . Comp .
1 48 .
1730 / CMP / 00060147 .WPD v1 35
87 . The Government further alleged that the practice o f
filing for services provided by unqualified personnel occurred
throughout HealthSouth facilities nationwide . For example :
• At a HealthSouth outpatient physical
therapy clinic in St . Petersburg,Florida supportive personnel often had
full patient schedules . U .S . Comp .
134(a) .
• At a HealthSouth outpatient
rehabilitation facility in Des Moines,
Iowa, HealthSouth physical therapists at
the facility were told that it wasexpected that they would team with onesupportive person and together they
would see 24 patients in an 8 hour day,
billing between $150-200 (or 4 units of
direct, one-on-one care) per patientvisit . The only way this goal could bemet was to have the supportive personnel
provide services directly to the
patient, and to bill those services asif the physical therapist had provided
the care . Id . 134(b) .
At a HealthSouth outpatient facility in
Scottsdale, Arizona, physical therapy
was provided to a patient by a certifiedathletic trainer . HealthSouth submitted
Medicare claims for interim payments to
Cahaba for the physical therapy as if it
had been performed by a physicaltherapist . Id. 135(b) .
At a HealthSouth outpatient facility in
Glen Burnie, Maryland on multipleoccasions in June 1995, the physical
therapy was rendered by a studentphysical therapist . HealthSouth
submitted Medicare claims for interim
payments to Cahaba for the physicaltherapy as if it had been performed by a
physical therapist . Id . 135(c) .
88 . The Cahaba investigation of HealthSouth's Medicar e
billing practices outlined above also found similar instances o f
1730 / CMP / 00060147 . WPD v1 36
billings for services provided by supportive personnel in a
substantial percentage of cases . In fact, Cahaba's review team
observed many instances of supportive personnel rendering
physical therapy services to patients during the on-site visits
to the 60 facilities . U .S . Comp . 1 36 .
89 . According to the Government's complaint, HealthSouth
also routinely sought reimbursement for outpatient physical
therapy services which in fact were not provided . For example,
after January 1, 1999, HealthSouth billed for direct care (one-
on-one) services when such services were not provided . U .S .
Comp . 1 46 . This allegation was corroborated by the Cahaba
investigation . Id .
90 . In addition, the Government charged HealthSouth with
billing for unskilled services as if they were skilled services .
HealthSouth also systematically billed Medicare for unskilled
services that were not reimbursable under Medicare . U .S . Comp .
Q 47 .
91 . Finally, the Government alleged that there were
numerous meetings, telephone conversations and other contacts
between Cahaba and HealthSouth at which various Medicare
regulations and billing issues were discussed since HealthSouth
selected Cahaba to be its national fiscal intermediary/carrier in
1995 . Despite these contacts, however, HealthSouth never sought
guidance from Cahaba concerning whether the Company's corporate
billing practices conflicted with Medicare reimbursement
regulations . U .S . Comp . 1 38 .
1730 / CMP / 00060147.WPD v1 3 7
The Darling Actio n
92 . In February of 2000, John Darling, another former
HealthSouth patient, filed an action (the "Darling Comp .")
against HealthSouth in the United States District Court for the
Middle District of Florida, Tampa Division, U. S . ex rel . Darling
vs . HealthSouth Sports Medicine & Rehabilitation Center o f
Clearwater LP, Case No . 8 :00-cv-416-T-26B, for improperly billing
Medicare for physical therapy (the "Darling Action") . The
allegations by Mr . Darling, which are based on Darling's personal
experience and similar to those made by Devage, charge that a
HealthSouth facility in Clearwater, Florida wrongfully upcoded
Darling's Medicare billings . Darling Comp . a 22 .
93 . Mr . Darling also alleged that HealthSouth billed for
therapy sessions by licensed therapists when in fact the therapy
received was provided by a low-paid, unlicenced employee with no
formal training whatsoever . Id . In addition to providing
therapy, this unlicenced employee also performed laundry and
cleaning functions . Nevertheless, he was dressed to look th e
same as the licensed therapists . Id . According to Mr . Darling,
the improper therapy practices at HealthSouth's Clearwater
Facility spanned a period of at least four years . Id .
94 . On February 28, 2002, the Government intervened as a
plaintiff in the Darling Action with respect to those allegations
asserting that HealthSouth "improperly billed government payers
for excessive units of one-on-one physical therapy services or
1730 / CMP / 00060147 .WPD v1 38
for physical therapy services performed by unlicenced personnel ."
In addition, the Government gave notice of its intention to
assert additional allegations not alleged in the Darling
complaint that HealthSouth "improperly billed government payers . "
The Mandel Action
95 . On or about October 1, 1999, another action (the
"Mandel Comp .") alleging similar misconduct was filed in the
United States District Court for the Southern District of New
York entitled U .S . ex . rel . Mark D. Mandel v. HealthSouth d/b/a
HealthSouth Network Services of NY IPA, Inc ., 99 Civ . 10184 (JSM)
(the "Mandel Action") .
96 . According to a signed Statement attached to hi s
complaint (the "Statement"), Mr . Mandel has 28 years of
experience in the "health and management fields encompassing
marketing, computer-based system design and installation,
research [and] teaching ." Statement T 2 . Mr . Mandel further
asserted that he holds a Master's Degree in Public
Administration, has been published "in many healthcare journals"
and "has been certified as an expert in healthcare reimbursement
in Federal Court ." Id . 1 3 .
97 . Based on his personal experiences at a HealthSout h
rehabilitation facility in New York City, Mr . Mandel alleged that
the Company was "[d]efraud[ing] the Medicare [p]rogram by
[m]isrepresenting the [n]ature of [t]heir [p]rovided [s]ervices" .
Mandel Comp ., at 5 . According to Mr . Mandel, in April 1999, he
1730 / CMP / 00060147 .WPD v1 39
received therapy from a HealthSouth facility in New York City for
treatment related to herniated discs . Statement 1 10 . Over his
objection, the therapy was provided by a student, not a certified
physical therapist . Id. 11 11-12 . When Mr . Mandel complained
about HealthSouth's practice, he was told by the physical
therapist supervising the student that there were four students
in the practice and that all patients were treated by students .
Id . 1 13 .
98 . Mr . Mandel further alleged that his insurance carrier,
The Prudential, was billed by HealthSouth "as if a licensed
physical therapist had delivered the care to me rather than the
practitioner (who is unlicensed and donates his services as part
of his educational requirements) ." Statement 1 16 . Based on the
fact that as part of the registration process HealthSouth had
provided the Relator with a number of documents pertaining to
Medicare reimbursement, Mr . Mandel alleged that the Company "has
defrauded the Medicare program and violated the False Claims Act
by billing Medicare in the same manner as HealthSouth billed The
Prudential in my case ." Id. 1 17 .
99 . At the request of the Government, the Mandel and
Darling Actions have been transferred to the United States
District Court for the Western District of Texas, San Antonio
Division, and consolidated with the Devage Action .
1730 / CMP / 00060147 .WPD vl 4 0
The Manning Action
100 . On August 18, 1999, an action was filed in the United
States District Court for the Northern District of Alabama
entitled U.S. ex. rel . Dewayne Manning v . HealthSouth Corp .,
Civil Action No . CV-99-B-2150-S (the "Manning Action") . In his
Complaint, Manning averred that he began employment with
HealthSouth as a physical therapist technician in May 1996 and
that the Company, among other wrongful acts, billed Government
payors for physical therapy services performed by unlicensed
personnel at outpatient rehabilitation facilities .
101 . On December 27, 2001, the Government intervened in th e
Manning Action to assert the foregoing claim . In addition, the
Government gave notice of its intention to assert additional
claims not alleged in the Manning Action that HealthSouth
"improperly billed government payors ." On May 8, 2002, the
Government withdrew its intervention based on the existence of
the earlier-filed cases alleging the same claims .
TRANSMITTAL 1753
102 . After years of clear direction from CMS on how to code
and bill for outpatient rehabilitative therapy -- Code 97150 for
group therapy consisting of 2 or more individuals, and Code 97110
for individual therapy - on May 17, 2002, CMS issued Transmittal
1753, effective July 1, 2002, which stated :
1730 / CMP / 00060147 .WPD v1 4 1
15302 .GROUP THERAPY SERVICES (CODE 97150 )
Pay for outpatient physical therapy services
(which includes outpatient speech-language
pathology services) and outpatientoccupational therapy services provided
simultaneously to two or more individuals by
a practitioner as group therapy services .
The individuals can be, but need not beperforming the same activity . The physician
or therapist involved in group therapy
services must be in constant attendance, but
one-on-one patient contact is not required .
103 . In issuing Transmittal 1753, CMS emphasized at the tim e
and thereafter, that the Transmittal was merely a reaffirmation
of the proper method of billing for therapeutic exercise and
procedures . That view was shared by leading commentators on
healthcare billing practices . For example, in its July 5, 2002
edition, Eli's Rehab Report (in an article that was circulated
among members of HealthSouth senior management) reported as
follows :
[1753 is] old news in a new package -- it
merely "manualizes" information that was
already noted in the Federal Register last
year . . . .
The American Physical Therapist
Association says the transmittal is inaccordance with what APTA has been telling
its members since the group therapy codes
were first added to the Federal Register in
1994 .
[Y]ou need to be careful to bill
individual CPT codes only if you are giving apatient one-on-one care . Otherwise you'rebilling for more time than you worked, which
would win you a government audit and fines .
If you're the only person in the room, youreally shouldn't be walking out with four
1730 / CMP / 00060147 .WPD V1 42
units of time for one hour [actuallyworked] . . . .
MISREPRESENTATIONS DURING THE CLASS PERIOD
104 . The Class Period begins on December 12, 2001, whe n
HealthSouth issued a press release representing that the Company
anticipated earning $1 .14 per share for the year ending December
31, 2002 . Defendant Scrushy was quoted in that press release as
stating : "We will continue in our efforts to reduce the cost of
healthcare services through hard work, innovation and efficiency,
and we expect that to be beneficial for our patients, physicians
and stockholders alike ." The release further represented : "The
guidance on HealthSouth's earnings objectives set forth above is
based on current budget goals and HealthSouth's assessment of
current conditions affecting its business . . . . HealthSouth
expects to update such guidance to reflect any material changes
in its expectations and objectives if and when it determines that
it is necessary or desirable to do so . "
105 . The foregoing representations were materially false an d
misleading . As detailed herein, HealthSouth's financial
forecasts and business model were predicated upon systematically
overcharging Medicare and other payors for the Company's
services . Accordingly, there was no reasonable basis for the
$1 .14 per share earnings estimate released by Defendants .
Similarly false and misleading was Defendants' representation
that the Company was taking steps "to reduce the cost o f
1730 / CMP / 00060147 .WPD v1 43
healthcare services," or that the Company's fraudulent activities
would be "beneficial for . . . stockholders . "
106 . On January 14, 2002, HealthSouth issued a press release
(the "January 14 Press Release") reiterating its earnings
guidance for the year ending December 31, 2002 . The Company
announced that it remained comfortable with its previously
announced earnings per share estimate of $1 .14 for 2002, and
Defendant Scrushy stated : "'We remain very excited about the
change from cost-based reimbursement to PPS . HealthSouth has
been an outspoken advocate of PPS in congressional and regulatory
circles for some time .," "PPS," or Prospective Payment System,
was the new reimbursement system implemented by Medicare
regulations .
107 . At the time the January 14 Press Release was issued ,
Defendants knew, or were reckless in not knowing, that
HealthSouth's practice of upcoding group therapy sessions and the
other unlawful practices described herein were inconsistent with
long- established Government coding and reimbursement policies,
thereby artificially inflating the Company' s revenues and
earnings . The earnings guidance provided in the January 14 Press
Release was premised on the continuation of this artificial
inflation of the Company's revenues and profits .
108 . On January 22, 2002, HealthSouth issued a press release
touting the accuracy of its "internal claims model" and
reaffirming its earnings per share guidance of $1 .14 per share
for 2002 . In the press release, HealthSouth represented that the
1730 / CMP / 00060147 .WPD v1 44
total payment received on the first claims submitted under PPS
was "identical" to that predicted by the Company's internal
model . Defendant Scrushy further represented : "'We are very
pleased that the first PPS payments are exactly what we expected,
validating the accuracy of our internal claims model . . . . We
remain comfortable with our 2002 earnings per share guidance of
$1 .14, which represents a 39% increase over consensus estimates
for 2001 .'"
109 . The foregoing statements were materially false and
misleading . As noted previously, HealthSouth's billing and
financial models were predicated upon upcoding and the other
unlawful billing practices detailed herein .
110 . On March 12, 2002, HealthSouth issued a press release
(the "March 12 Press Release") announcing financial results for
the fourth quarter and year ended December 31, 2001 . That Press
Release stated in part as follows :
For the quarter, HealthSouth's revenues were$1 .115 billion, an increase of 3 .5% as
compared to $1 .077 billion for the fourthquarter of 2000 and an increase of 7 .5% afteradjusting in both periods for divestitures in
2001 . Income before unusual and non-
recurring items for the 2001 quarter was$88 .6 million, an increase of 15 .2% compared
to net income of $76 .9 million in the 2000
quarter . The comparable income per share(assuming dilution) was $ .22 for the 2001
quarter, consistent with consensus Wall
Street estimates, an increase of 15 .8% ascompared to earnings per share (assumingdilution) of $ .19 in the 2000 quarter . For
the year ended December 31, 2001,HealthSouth's revenues were $4 .380 billion,
compared to $4 .195 billion for 2000 . Incomebefore unusual and non-recurring items for
1730 / CMP / 00060147.WPD vl 45
2001 was $326 .1 million, compared to net
income of $278 .5 million for 2000 . The
comparable income per share ( assuming
dilution) for 2001 was $ .82, a 15 .5% increase
compared to net income per share (assuming
dilution) of $ .71 for 2000 .
111 . In the March 12 Press Release , Defendant Scrushy
stated :
`Our fourth quarter results reflect a strong
finish to a very successful year . . . . The
fundamentals of our business showed continuedimprovement, as same-store volume growth
ranged from 6 .5% to 13% in our outpatient
lines of business compared to the fourth
quarter of 2000 . Pricing trends were alsostrong on both a sequential quarter and year-
over-year basis, contributing to an increase
in our EBITDA margin to 28 .2% . Looking
ahead, our early experience under the newinpatient rehabilitation prospective payment
system is confirming our expectations for thepositive impact that PPS will have on our
business . . . . We are proud of our performancelast year, and we are committed to strategic
growth, continued innovation and strong
financial performance in 2002 . '
112 . The revenues, earnings and margins reported in th e
March 12 Press Release were artificially and materially inflated
through the Company's systematic overbilling of Medicare and
other payors through upcoding of group therapy sessions and the
other improper billing practices described herein . Similarly,
the "commit[ment] to . . . strong financial performance in 2002"
was also predicated upon a continuation of inflated billings to
the Government .
113 . On that same day, HealthSouth hosted a conference call
for investors and securities analysts moderated by Defendant
Scrushy . During that call, Defendant Scrushy represented :
1730 I CMP / 00060147 .WPD vl 4 6
Now as far as the financial outlook, we'revery comfortable with the 28 to 29 percent
EBITDA margin for 102 . Very comfortable with
the consensus EPS estimate of $1 .14 for 2002,
and that represents 39 percent earnings
growth from where we were . We're verycomfortable with a sustained EPS growth of 15
percent or greater per year .
The foregoing representations were materially false and
misleading . As Scrushy knew, or was reckless in not knowing,
HealthSouth's reported and projected earnings and EBITDA margins
were predicated on upcoding and other improper Medicare billing
practices which artificially inflated the Company's revenues,
earnings, and margins .
114 . In an interview with CNBC Anchor Ted David on March 12 ,
2002, Defendant Scrushy falsely represented that HealthSouth was
poised for "a very strong year and I think everybody knows it ."
This assertion was also materially false and misleading, a s
HealthSouth was fast approaching the end of its deceptive
practices .
115 . On March 27, 2002, HealthSouth filed with the SEC the
2001 Form 10-K (for the year ended December 31, 2001) signed by,
inter alia, each of the individual Defendants . In that 10-K,
Defendants represented as follows :
Medicare Participation and Reimbursemen t
In order to participate in the Medicare
program and receive Medicare reimbursement,each facility must comply with the applicable
regulations of the United States Departmentof Health and Human Services . . . . All of our
inpatient facilities participate in theMedicare program . All of our surgery centers
and 121 of our diagnostic centers ar e
1730 / CMP / 00060147.WPD vl 47
certified (or awaiting certification) under
the Medicare program . Our Medicare-certified
facilities, inpatient and outpatient, undergo
annual on-site Medicare certification surveys
in order to maintain their certificationstatus . Failure to comply with the program's
conditions of participation may result in
loss of program reimbursement or other
governmental sanctions . We have developed
our operational systems to attempt to assure
compliance with the various standards and
requirements of the Medicare program and have
established ongoing assurance activities to
monitor compliance .
(Emphasis added . )
116 . The foregoing representations in the 2001 Form 10- K
were materially false and misleading . As detailed herein, the
Company's "operational systems" were designed to systematically
overcharge Medicare and other payors through upcoding and other
improper billing practices, not "to assure compliance with the
various standards and requirements of the Medicare program ."
Similarly, the Company was engaged in a concerted effort to avoid
rather than "assur[e] . . . compliance," with the Government's
billing procedures .
117 . In April 2002, Defendant Scrushy determined that h e
would exercise options due to expire on May 14, 2002, to purchase
5,275,360 shares of HealthSouth common stock at an exercise price
of $3 .7825 per share . Scrushy also determined at that time that
he would sell all of the underlying shares upon exercise of the
options . Defendant Owens was fully aware of Scrushy's plans .
118 . On May 2, 2002, Defendants caused HealthSouth to issue
a press release announcing the Company's financial results fo r
1730 / CMP / 00060147 .WPD vl 4 8
the first quarter ended March 31, 2002 (the "May 2 Pres s
Release ") . That Press Release contained the following
representations , among others :
For the first quarter, HealthSouth's revenueswere $1 .130 billion, an increase of 3 .6% as
compared to $1 .090 billion for the firstquarter of 2001 and an increase of 8 .8% after
adjusting in both periods for divestitures in
2001 . Net income for the 2002 quarter was
$107 .7 million, an increase of 43% comparedto net income of $75 .3 million in the 2001
quarter . Earnings per share (assuming
dilution) were $ .27 for the 2002 quarter,consistent with consensus Wall Street
estimates, an increase of 42% as compared to
earnings per share (assuming dilution) of
$ .19 in the 2001 quarter . For the quarter,the company's earnings before interest,
taxes, depreciation and amortization (EBITDA)
margin was 29 .1% compared to 27 .3% in thefirst quarter of 2001 .
119 . Defendant Scrushy was quoted in the May 2 Press Releas e
as follows :
"We showed strong operational performance inthe first quarter of 2002 . . . . Our first waveof inpatient rehabilitation facilities movedinto the new inpatient rehabilitationprospective payment system beginning January1, and just as we had projected, PPS had a
positive impact on our bottom line . We have
spent years preparing for this change,lowering our costs and increasing our
efficiencies, and our initial PPS payments
have continued to come in on target with ourpreliminary estimates . In addition, we saw
strong same-store volume growth in all of ourambulatory lines and in our inpatient
rehabilitation facilities . We are especially
pleased to report the seventh consecutivequarter of increases in same-store volume in
our surgery centers . Given these positivetrends, we are actively pursuing additional
strategic growth and development ofopportunities across our product lines .
After a very successful 2001, the firs t
1730 / CMP / 00060147 .WPD v1 49
quarter has positioned us well to moveforward to a new level in 2002 . "
120 . The revenues and earnings reported in the May 2 Press
Release were artificially and materially inflated through the
systematic upcoding and other improper billing practices, which
Defendants knew, or were reckless in not knowing, were improper
under long-established CMS coding and reimbursement policies .
Moreover, at the time of the May 2 Press Release, Defendant
Scrushy knew, but did not disclose, that he would be selling
5,275,360 HealthSouth shares in less than two weeks .
121 . Defendants held a conference call with the financia l
community on May 2 (the "May 2 Conference Call") to discuss
HealthSouth's recently released financial results for the quarter
ended March 31, 2002 and future prospects . Each of the
Individual Defendants participated in the Conference Call with
Defendant Scrushy acting as the principal Company spokesman .
During his presentation, Defendant Scrushy reaffirmed, "our 2002
financial outlook, we are very comfortable with a 28 to 30%
ebitda margin for 102 . We are very comfortable with a consensus
eps estimate of $1 .14 for this year, represent[ing] a 39%
earnings growth . . . . "
122 . At the time of the May 2 Conference Call, Defendant
Scrushy knew, or was reckless in not knowing, that HealthSouth's
improper billing practices were artificially inflating the
Company's revenues, profits, and margins . The financial results
and guidance provided during the May 2 Conference Call wer e
1730 / CMP / 00060147_WPD vl 5 0
premised on the continuation of the improper billing practices .
Moreover, Defendant Scrushy had already determined, but did not
disclose, that he would be selling more than 5,200,000 shares of
HealthSouth common stock twelve days later, when he exercised his
stock options on May 14 .
123 . During the May 2 Conference Call, defendant Scrush y
announced that HealthSouth would be hosting an "investor day" in
Birmingham on May 14, 2002 and invited all the participants on
the call to attend . Scrushy explained that the attendees would
be given access to "well over 100 people that are in leadership
positions in our company . We will have our market managers, our
market leaders, senior executives and the middle management . We
have numerous presentations that will present our current
situation as well as our plans . . . ." And, later in the May 2
Conference Call, Scrushy told the participants that he had to
conclude his participation in order to make a planned appearance
on CNBC, the financial news television network .
124 . Defendant Scrushy was then interviewed concerning
HealthSouth's financial condition and stock price on CNBC on May
2, 2002 . In the interview, when asked by CNBC anchor Ted Davis,
"Where do you see your company fairly valued?" Defendant Scrushy
answered :
Well, I think the company should be north of$20 a share right now . I mean certainly weshould trade at our growth rate . And, weshould trade, you know, our company has a,you know, strong cash flow. You know, we,certainly should be higher than we are now .
1730 / CMP / 00060147 .WPD v1 5 1
I would expect to see the company in the 20s,
and that's [where] we're headed, we believe .
(Emphasis added . )
125 . Defendants' numerous misrepresentations on May 2 ha d
their intended effect . In response to those representations,
HealthSouth shares rose on that day to a Class Period high of
$15 .90 per share . Yet, the foregoing representations, among
others, that (a) the price of HealthSouth shares should be "north
of $20 a share right now ;" (b) HealthSouth shares "certainly . . .
should trade at our growth rate ;" (c) the Company was
experiencing "strong cash flow ;" (d) HealthSouth's stock price
"certainly should be higher than we are now ;" and (e) the
Company's stock price was "headed" into the "20s," were
materially false and misleading . Defendants knew, or were
reckless in not knowing, that the systematic upcoding and other
improper billing practices at HealthSouth had been artificially
inflating the Company's revenues, "growth rate," "cash flow," and
stock price . Moreover, Defendant Scrushy did not disclose that
he had already determined to sell more than 5,200,000 shares of
HealthSouth common stock just twelve days later .
126 . On May 10, 2002, HealthSouth filed with the SEC a
report on Form 10-Q for the quarter ending March 31, 2002 (the
"First Quarter 10-Q") . That report, signed by Defendants Scrushy
and Smith, repeated the financial results contained in the May 2
press release . The revenues and earnings reported in the First
Quarter 10-Q were artificially and materially inflated throug h
1730 / CMP / 00060147 .WPD v . 52
the Company's systematic pattern of billing improprieties, which
the Defendants knew, or were reckless in not knowing, was
improper under long-established CMS coding and reimbursement
policies .
127 . The numerous misrepresentations by Defendants durin g
the Class Period repeatedly caused securities analysts to
recommend the purchase of HealthSouth shares . For example, in a
report dated May 13, 2002 (one day before Defendant Scrushy sold
more than 5,200,000 shares), Lehman Brothers, Inc . ("Lehman
Brothers") issued a "Strong Buy" on HealthSouth shares and set a
"target" price of $22 per share . Lehman Brothers advised its
clients that HealthSouth shares represented "an attractive
risk/reward scenario analysis with little downside from current
levels (which we would peg in the $11-$12 range), in our view,
and solid upside potential for possibly a 40-50%+ return if the
shares reach the $19-$22 level which we have determined as fair
value . "
128 . On May 14, 2002, Defendant Scrushy exercised options t o
purchase 5,275,360 HealthSouth shares at an exercise price of
$3 .7825 per share and sold all of the shares at $14 .05 per share
for gross proceeds exceeding $74 million . The selling price of
$14 .05 per share was near the Class Period high price of $15 .90,
reached on May 2, 2002 .
129 . On that same day, the Company hosted its "Investor Day"
for securities analysts and investors to tout the Company and its
financial prospects (see 1 123, supra) . Merrill Lynch Capital
1730 / CMP / 00060147 .WPD vl 53
Markets ("Merrill Lynch") described the Investor Day presentation
as "upbeat" in a comment circulated to brokers and analysts .
130 . Also on May 14, HealthSouth issued a press release
disclosing the foregoing stock option exercise and sale of
HealthSouth shares by Defendant Scrushy and representing that he
had "no intention of selling additional shares in the near
future ." Additionally, in addressing the sales during his
Investor Day presentation, Scrushy stated that he planned to use
the proceeds of the sales to pay down a loan from the Company .
The foregoing disclosures were materially false and incomplete
because, at the time, Defendant Scrushy was negotiating to repay,
with additional HealthSouth shares, a $25 million loan owed to
HealthSouth .
131 . A few days later, on may 17, 2002, CMS issued
Transmittal 1753 (9[ 5 102-03, supra) . It was readily available on
the CMS website, as well as widely disseminated within the
healthcare industry . Numerous employees of HealthSouth received
copies of the transmittal within days of its issuance, including
Defendant Owens . Transmittal 1753 was also a supplement to the
CMS Carrier Manual, Part 3 -- Program Administration (CMS Pub .
14-3), covering the period April-June 2002 .
132 . Within days of its issuance , numerous senior executives
within HealthSouth, including Defendant Owens, were considering
the impact of Transmittal 1753 on HealthSouth' s business and
revenues from outpatient physical therapy . The issuance of
Transmittal 1753 made two things immediately clear : (i) the
1730 / CMP / 00060147 . WPD v1 54
Company could no longer ignore the plain language of CPT Codes
97110 and 97150, and (ii) the switch to proper billing practices
would have a significant adverse impact on the Company's
revenues, profits, costs and margins .
133 . On June 7 and 11, 2002, George H . Strong ("Strong"), a
Director of HealthSouth and Chairman of the Audit Committee, sold
(for his personal account or through trusts he had established)
52,125 HealthSouth shares at $13 .78 per share and 17,216 shares
at $14 .28 per share, respectively, for total proceeds exceeding
$900,000 . Additionally, earlier in the Class Period, on February
13-15, 2002, Strong had sold or disposed of an aggregate of
46,525 shares for proceeds exceeding $550,000 . Strong's sales
during the Class Period, which are detailed in paragraph 173,
infra, resulted in total proceeds exceeding $1,500,000 .
134 . On June 11, 2002, Defendants Owens and Malcolm E . McVay
("McVay"), Treasurer of HealthSouth, were the featured speakers
at a breakfast in New York on HealthSouth for investors and
analysts hosted by Lehman Brothers . During their presentation,
Owens and his subordinate continued to portray a rosy outlook for
HealthSouth, even though they were aware at the time that
Transmittal 1753 would cause the Company to change significantly
its coding and billing practices for therapy sessions with
Medicare patients .
135 . Following that upbeat presentation by Defendant Owens
and HealthSouth's Treasurer, Lehman Brothers issued a report
dated June 17, 2002 reiterating a "Strong Buy" recommendation on
1730 / CMP / 00060147 .WPD v1 5 5
HealthSouth shares . After summarizing the positive statements by
Owens and his subordinate, Lehman Brothers concluded : "We still
highlight an attractive risk/reward scenario analysis with little
downside risk from current levels (which we would peg in the $11-
$12 range), in our view, and solid upside potential for possibly
a 40-50%+ return if the shares reach the $19-$22 level which we
have determined as fair value . Thus we continue to recommend
purchase of the shares of HRC with a STRONG BUY rating . "
136 . On July 11, 2002, HealthSouth issued a press releas e
entitled "HealthSouth Confirms Guidance for 2002" (the "July 11
Press Release"), in which Defendants proclaimed comfort with the
consensus Wall Street earnings estimates for the remainder of
2002 . Defendant Scrushy was quoted in part as follows :
"We have had strong operating results throughthe first half of 2002 . . . . While the current
market instability has had an adverse affect
on our stock price, the fundamentals of our
business continue to be solid, and we remainconfident in our guidance for the rest of the
year . "
137 . Defendants issued the materially false and misleadin g
July 11 Press Release to stabilize the market price of
HealthSouth shares . At the time of the issuance of the release,
Defendants were aware of Transmittal 1753 and that implementation
of appropriate coding, billing and reimbursement procedures would
have a material adverse impact on the Company's revenues and
earnings . In addition, Defendants Scrushy and Owens knew that
the terms of a forthcoming sale of stock by Scrushy to the
Company to satisfy an outstanding $25 million loan had bee n
1730 / CMP / 00060147 .WPD v1 5 6
finalized ; and the transaction was scheduled to close at the end
of July, with the value of the shares to be calculated at their
market price on the date of the closing . Accordingly, Scrushy
and his subordinate Owens had every reason to attempt to maximize
the market price of HealthSouth shares, in order to limit the
number of shares Scrushy needed to sell to satisfy his
outstanding loan obligation .
138 . Issuance of the July 11 Press Release had its intende d
effect . In a report dated July 12, 2002, Merrill Lynch raised
its recommendation on HealthSouth shares from "NEUTRAL" to a
"STRONG BUY ." Merrill Lynch based its reco mmendation on the
representations by Defendants in the July 11 Press Release that
"management . . . knew of no reason for the recent decline on its
stock price and it remained confident in its guidance for the
rest of the year . "
139 . A favorable analysis of HealthSouth and its shares als o
appeared in the July 29, 2002 edition of Barron's, the weekly
financial periodical (the "July 29 Article") . (That edition was
first publicly disseminated on Saturday, July 27, 2002 .) Based
in large measure on discussions with Defendant Scrushy and
Defendants' false and misleading public statements, Barron's told
its readers in the July 29 Article that HealthSouth's shares were
poised to rise . Baryon's explained its reasoning as follows :
HealthSouth . . . has been recklessly diagnosedin the past few months with some of the same
management and accounting ills that havesapped the broader market's vigor . The
experience has cost the company more than
1730 / CMP / 00060147.WPD v1 57
half its market value, leaving its shares ata recent 7 .66 .
Yet HealthSouth is poised to heal itself
by meeting its profit targets for the second
quarter and the year, and by convincing Wall
Street that its books are as clean as, yes,an operating room . As investors grow to
appreciate the strength of the company's
markets, the fitness of its balance sheet and
the false nature of the charges that have
tarred HealthSouth, its limpid shares are aptto regain not just a pulse but the healthy
glow they sported before suspicion cloudedsense as the market's driving force .Specifically, with just a modest revaluation,
the stock could return at least to the mid-
teens .
140 . Defendants' misrepresentations induced Barron's to
issue the materially false and misleading statements contained in
the July 29 Article . In fact, HealthSouth was not poised to meet
its profit targets and Defendants did not warn Barron's tha t
compliance with the Government's billing requirements would
materially reduce HealthSouth's earnings and revenues .
141 . On July 31, 2002, Defendant Scrushy completed his sal e
to the Company of 2,506,770 shares of HealthSouth stock at $10 .0 6
per share .
142 . According to an article published by Forbes .com on
October 14, 2002, the underlying loan agreement between Defendant
Scrushy and HealthSouth required that it obtain a fairness
opinion from an independent investment bank in connection with
the transaction . According to Forbes .com, which obtained a
response from Defendant Scrushy on the matter that avoided th e
1730 / CMP / 00060147 .WPD v1 5 8
question, that independent fairness opinion was never obtained by
HealthSouth .
143 . On August 7, 2002, Defendants issued a press releas e
(the "August 7 Press Release ") reporting that HealthSouth ha d
recorded strong financial results for the second quarter ende d
June 30, 2002 . The press release stated :
For the second quarter, HealthSouth's
revenues were $1 .164 billion, an increase of5 .9% as compared to $1 .099 billion for the
second quarter of 2001 and an increase of
8 .6% after adjusting for divestitures in2001 . Operating earnings for the 2002
quarter were $113 .7 million, an increase of
36 .8% compared to operating earnings of $83 .1
million in the 2001 quarter . Operatingearnings per share (assuming dilution) were
$0 .28 for the 2002 quarter, consistent with
consensus Wall Street estimates, an increase
of 33 .3% as compared to operating earnings
per share (assuming dilution) of $0 .21 in the
2001 quarter . For the quarter, the Company's
earnings before interest, taxes, depreciation
and amortization (EBITDA) margin, excludingunusual and non-recurring items, was 29 .8%,compared to 28 .1% in the second quarter of
2001 .
144 . Commenting on the strong revenues for the secon d
quarter of 2002, Defendant Scrushy highlighted strong growth fo r
all the Company's product lines and announced that the Company
was close to completing a $1 billion note offering :
"The second quarter showed strength across
all product lines with each of our businesses
demonstrating continued positive volume andpricing trends . "
The revenues, earnings and margins reported in the August 7 Pres s
Release were materially inflated through the Company's systemati c
upcoding of group therapy sessions to individual sessions and th e
1730 / CMP / 00060147 .WPD v1 59
other improper billing practices described herein . Defendants
knew, or were reckless in not knowing, these actions were
improper under long-established CMS coding and reimbursement
policies .
145 . HealthSouth held a conference call that day wit h
securities analysts and investors to discuss the Company's second
quarter financial results . Each of the Individual Defendants
participated in the Conference Call with Defendant Scrushy acting
as the principal Company spokesman . During his presentation,
Defendant Scrushy emphasized the Company's "[v]ery strong second
quarter results" in which HealthSouth recorded "record quarter
revenues," met analyst consensus earnings per share estimates of
$ .20 and "continued our EBITDA margins improvement" -- results
all achieved through systematic upcoding of Medicare billings and
the other unlawful practices detailed herein . Moreover,
Defendants made no mention of Transmittal 1753 or the impact
compliance with the Government's billing procedures would have on
the financial condition, revenues, earnings and margins of the
Company .
146 . Three days after the Company released its secon d
quarter results of operations, a follow-up article appeared in
Barron's . In an article in its August 12, 2002 edition (first
disseminated to the public on August 10), Barron's reported that
the Company's stock price had risen since the publication of its
previous article and HealthSouth's release of second quarter
results of operations :
1730 / CMP / 00060147.WPD v1 6 0
Barron ' s argued in a recent profile of
HealthSouth ("Down, Not Out," July 29) thatthese charges were misplaced or exaggerated
and that the company ' s shares represented a
compelling opportunity to play an attractive
part of the health- care business at a bargainprice .
The shares began to recover thereafter, atrend that continued through last week, whenthe company' s second quarter earnings report
gave tangible evidence of progress on allfronts .
147 . The foregoing positive statements by Barron's were
based on the false assumption that the Company's second-quarter
earnings report and the numerous positive representations made by
Defendants were accurate and complete . In fact, Defendants had
failed to disclose the following adverse facts, among others :
a . Defendants ' repeated reassurances that the
Company's fundamentals were strong and that the Company woul d
meet its earnings targets for 2002 were lacking any reasonabl e
basis ;
b . Defendants had known for years that the Company
was not billing for outpatient individual and group physical an d
rehabilitation therapy in accordance with Medicare reimbursement
regulations and policies ;
c . the CMS directive set forth in Transmittal 175 3
would materially reduce the Company's revenues and earnings an d
increase its expenses going forward ; and
d . substantial expense and disruption would b e
incurred retraining Company personnel and otherwise bringing th e
1730 / CMP / 00060147 .WPD v1 6 1
Company's billing practices and procedures into compliance with
the long-standing applicable CMS rules and regulations .
148 . On August 14, 2002, HealthSouth filed with the SEC a
report on Form 10-Q for the quarter ended June 30, 2002 (the
"Second Quarter 10-Q") . The Second Quarter 10-Q was signed by
Defendants Scrushy and Smith and repeated the false financial
representations contained in the August 7 Press Release .
149 . On that same day, the Company filed with the SEC a
Report on Form 8-K (the "8-K Form") signed by Defendants Scrushy
and Smith . That filing was made in response to SEC Order 4-460,
requiring senior executives of nearly 1,000 publicly trade d
corporations to file sworn statements attesting to the accuracy
of, among other public filings, their companies' most recent
annual and quarterly financial reports .
150 . In the Form 8-K, Defendants Scrushy and Smith each
represented under oath the following with respect to the
Company's "covered report[s]," which expressly included the 2001
Form 10-K and the Second Quarter 10-Q :
no covered report contained an untrue
statement of a material fact as of end of theperiod covered by such report . . . and
no covered report omitted to state a materialfact necessary to make the statements in thecovered report, in light of the circumstancesunder which they were made, not misleading asof the end of the period covered by suchreport . . . .
151 . The foregoing representations in the Form 8-K were
materially false and misleading because they failed to disclose ,
1730 / CMP / 00060147 . WPD v1 62
among other adverse facts, that HealthSouth's "covered report[s]"
had been based on revenues and earnings predicated upon upcoding
and the other unlawful billing practices detailed herein .
Indeed, as of the date of the issuance of the Form 8-K (and
Second Quarter 10-Q), defendants or their subordinates were
finalizing their computations confirming that the Company's
belated steps to comply with the Government's long-standing
Medicare reimbursement policies would have a material adverse
effect on the revenues, earnings and margins of HealthSouth .
THE TRUTH BEGINS TO EMERGE
The August 27 Press Release Causes
HealthSouth Shares to Plunce In Pric e
152 . On August 27, 2002, prior to the commencement of
trading in HealthSouth shares, the Company stunned the investment
community by announcing that it was reducing its earnings
guidance by $175 million annually, and discontinuing and
disavowing the earnings guidance it had previously given to
investors for 2002 and 2003 . In an effort to distract attention
from the real causes of this development -- the Company's
unlawful upcoding and other overbilling practices -- Defendants
falsely claimed that the Medicare rules on outpatient individual
and group therapy billing had been changed by the Government .
153 . The Company further tried to soften the blow by
announcing the proposed separation of its Surgery Center Division
into a new public company, and changes in senior management, with
1730 / CMP / 00060147 .WPD v1 63
Defendant Scrushy serving as Chairman of the Board of the new
surgery center company ; Defendant Owens becoming Chief Executive
Officer of HealthSouth ; Defendant Smith assuming responsibility
for implementing the proposed transaction ; and McVay, then
HealthSouth Executive Vice President and Treasurer, becoming
Chief Financial Officer of HealthSouth . Additionally,
HealthSouth announced that it had hired the investment banking
firm of UBS Warburg LLC to assist "in evaluating potential
divestitures and other strategies . "
154 . The August 27, 2002 press release (the "August 27 Press
Release") stated in part as follows :
The company indicated that it was moving
forward with the separation plan at this time
in part because of unfavorable developmentsin outpatient therapy reimbursement .
Effective July 1, the Centers for Medicare
and Medicaid Services ("CMS") issued a
directive to Medicare Part B carriersrequiring that outpatient therapy services
provided to two or more patients in a single
time period be paid for under the "grouptherapy" payment code, regardless of whether
such patients were engaged in the same
activity . This directive, whichsignificantly lowers reimbursement for
services previously paid as individual
therapy, is inconsistent with many providers'understanding of appropriate coding practice,
which looks to the nature of the services
provided and the clinical judgment of thetherapist to determine whether the group code
or individual codes are appropriate .
Because this program transmittal was not
directed to Medicare providers or to MedicarePart A fiscal intermediaries, who administer
payments under Part B to rehabilitationagencies such as those typically operated byHealthSouth, and because it appears to
conflict with other statements by CMS an d
1730 / CMP / 00060147 .WPD v1 64
practices followed in the therapy industry,
there has been substantial confusion
regarding the impact and applicability of the
directive . HealthSouth sought clarification
through several meetings with its national
medicare intermediary and CMS officials in
July and August and continued to receive
somewhat conflicting guidance . However,
pending further clarification , the company
has implemented policies and proceduresdesigned to reflect a conservative
interpretation of current Medicare coding
requirements in light of the recentdirective . Management believes that, over
time , it will be able to adjust scheduling
and staffing patterns to reduce the negativeimpact of this new interpretation . However,compliance with the conservative policies
will adversely impact its revenues and
expenses relating to outpatientrehabilitation services in the near term . . . .
. . . [T]he company currently believes that the
impact of this reimbursement change will
require material revisions to its business
model and operating strategy in outpatientrehabilitation . In light of this assessment,
and based on available information, the
company currently believes that its earnings
before interest, taxes, depreciation andamortization will be lower than previously
projected by approximately $175 millionannually . Because of the uncertaintiessurrounding the full impact of these
developments at this time, this initialassessment may prove incorrect, and thecompany is accordingly discontinuing earnings
guidance for the remainder of 2002 and 2003
at this time .
155 . Investor reaction to the shocking revelations containe d
in the August 27 Press Release was immediate and adverse .
HealthSouth shares closed at $11 .97 per share on August 26, 2002 .
On August 27, HealthSouth shares plunged to a closing price of
$6 .71 per share on extraordinarily heavy volume exceeding 42 .5
million shares ; and the following day, August 28, HealthSout h
1730 1 CMP / 0 0060147 .WPD vl 65
shares declined to a closing price of $5 .05 per share on volume
exceeding 42 .1 million shares . Accordingly, HealthSouth shares
lost nearly 60 percent of their value in just two days o f
trading . As further adverse news has been released by
Defendants, the price of HealthSouth shares has continued to
decline .
Defendants ' Explanations Are Discredited
156 . Knowledgeable Government and industry executive s
disputed Defendants' claim that there had been a change in the
Government's billing practices or procedures . For example, on
August 27, 2002, CMS Administrator Tom Scully was quoted by
Reuters as follows :
I know those guys well, I'm astounded by(their claims) . We made that decision in Mayand they never called me . If this were such abig problem for them, why am I just hearingabout this now?
157 . Similarly, Frank Mallon, chief executive of APTA ,
confirmed in the September 6, 2002 edition of The New York Times
that the group-billing rule had been accepted practice for many
years : "He said the group-billing rule had been accepte d
practice by the association since Medicare first announced it in
The Federal Register in 1994 and repeated the ruling in 1996 . "
158 . And, on August 27, 2002, The Wall Street Journal online
reported that RehabCare Group, a competitor of HealthSouth which
derives 9% of its revenue from outpatient rehabilitation, 30% of
which comes from Medicare, was unaffected by the CMS transmittal .
1730 / CMP / 00060147 .WPD v1 6 6
As Alan Henderson, the Chief Financial Officer of RehabCare Group
explained : "`We looked at the interpretation several years ago
and changed our practices at that time,' Henderson said . 'We
don't do concurrent therapy and bill for it at the individual
therapy rates . We bill it as concurrent therapy . It just
depends on what's appropriate .'"
159 . Former Employee No . 1 said of the August 2 7
announcement that "they [HealthSouth] must have had their head in
the sand not to know of CMS's consistent policy on outpatien t
individual and group therapy billing . "
160 . The reaction by securities analysts was equall y
skeptical . An article in the August 28, 2002 edition of The Wall
Street Journal reported that analysts were "shocked" at the
Company's belated disclosures, and that the Company had lost its
credibility :
Analysts said they were shocked, particularlysince the company didn't mention the Medicareissue in either its earnings conference callearlier this month, or in its quarterl yfinancial filing . . . . HealthSouth . . . has"lost credibility . "
161 . In response to the adverse disclosures and loss o f
credibility, a large number of securities analysts downgraded
their recommendations on HealthSouth shares on August 27, 2002 .
The brokerage firms issuing those downgrades included Lehman
Brothers ; Jeffries & Company ; U .S . Bancorp Piper Jaffray ; Salomon
Smith Barney ; UBS Warburg LLC (which had just been retained b y
1730 / CMP / 00060147 .WPD v1 67
HealthSouth for advice in connection with the potential
divestitures) ; and H&R Block Financial Advisors .
The SEC Investigation
162 . On September 19, 2002, HealthSouth announced that it
was the target of an SEC investigation . As reported in the
September 19, 2002 edition of The Wall Street Journal, the
investigation is "focusing in part on accounting issues and
trading in the company's stock, a person familiar with the matte r
said ." Over the next few days it was further reported that the
Company had received from the SEC a wide-ranging request for the
production of documents on the matter, including document s
concerning reports filed with CMS, the sales of HealthSouth
shares by Defendant Scrushy and the disclosures contained in the
August 27 Press Release .
163 . On February 26, 2003, HealthSouth issued a press
release (the "February 26 Press Release") in response to a
"number of news media" reports on the SEC investigation . In that
press release, the Company
confirm[ed] that it has recently learned that
the SEC has issued an "Order DirectingPrivate Investigation and Designating
Officers to Take Testimony" - commonly
referred to as a "formal order ofinvestigation" -- in connection with the
investigation . The company understands thatthe SEC is investigating possible violations
of Section 11(a) of the Securities Act of1933 and Sections 10(b), 13(a) and13(b)(2)(A) and (B) of the Securities
Exchange Act of 1934 and Rules 10b-5, 12b-20,
13a-13, 13b2-1 and 13b2-2 thereunder .
1730 / CMP / 00060147 .WPD v1 68
The February 26 Press Release was filed by HealthSouth with the
SEC as part of a Form 8 -K, dated February 27, 2003 .
The Ratings Downgrades and Other Adverse Business Developments
164 . Following the announcement of the SEC investigation ,
Standard & Poor's ("S&P"), the ratings agency, slashed its
ratings on HealthSouth bonds to junk status and said it might
lower the ratings even further . Specifically, S&P lowered
HealthSouth senior unsecured debt two notches to "BB", its
second-highest junk grade, from "BBB-" . The Company had
approximately $3 .3 billion of debt at the end of June . As
further disclosed in the financial press, a downgrade raises
HealthSouth's borrowing costs . In response to the foregoing
additional adverse disclosures and others concerning HealthSouth
and its executives, Company shares declined to the $3 .00 per
share range .
165 . On October 16, 2002, HealthSouth announced that it was
suspending the planned spinoff of its surgery center division .
In a cryptic explanation, Defendant Scrushy stated : "Based on
comments we have received from some of our investors and lenders
and conditions in the debt and equity markets, we have determined
that it does not make economic sense at this time to proceed
with" the transaction .
166 . On November 5, 2002, HealthSouth announced that its net
income for the third quarter of 2002 had plunged to $53 .6
million, or $ .13 per share, from $79 .1 million, or $ .20 per
1730 / CMP / 00060147 .WPD v1 69
share, in the comparable quarter of the prior year . Defendants
Scrushy and Owens acknowledged during a conference call that day
with investors and securities analysts to discuss the quarterly
results that compliance with the Government's Medicare billing
regulations had caused the decline by reducing the Company's
revenues and increasing expenses . Owens further acknowledged
that "there will be some ongoing costs related to therapist
retraining in light of [Transmittal] 1753" and the Company would
have to make "meaningful" cost reductions "across the board" as
HealthSouth struggled to improve its financial condition and
performance .
167 . On November 14, 2002, HealthSouth filed with the SEC a
Report on Form 10-Q for the quarter ended September 30, 2002 (the
"Third Quarter 10-Q") . That report was signed by Defendant
Owens, as President and Chief Executive Officer ; and the
Company's then Chief Financial Officer . In the Third Quarter
10-Q, Defendants belatedly acknowledged that HealthSouth's
results of operations had been "significantly affected" by the
Company's compliance with CMS Transmittal 1753 . Although
continuing falsely to portray Transmittal 1753 as a "new" or
"change[d]" Government policy, Defendants described the adverse
impact of the Company's compliance with the operative rules and
regulations as follows :
[P]roviders of outpatient therapy
services are required to use the so-called"group therapy" procedure code for billing
Medicare when a therapist provides servicesto more than one patient during a single tim e
1730 / CMP / 00060147 .WPD v1 7 0
period, rather than using individual
procedure codes to reflect the specific
services provided to the patients . The group
therapy code provides for significantly lower
reimbursement to therapy providers than do
individual procedure codes . During the
quarter, we announced that we expected the
impact of this change to reduce our pretax
earnings by approximately $175,000,000 per
year, taking into account our estimates of
diminished Medicare revenue and diminishedrevenue from other payors who follow Medicare
payment policies . . . .
As a result, in part, of the demands on
management resources brought about by theseevents, the confusion among our therapists on
scheduling and staffing requirements under
the new Medicare policy, and the efforts ofcompeting providers to use the substantial
adverse publicity surrounding these events to
divert business from our facilities, we saw a
decline in volumes in our outpatient
rehabilitation line of business during thequarter . When compared to the second quarterof 2002, we saw a decrease in reimbursement
of approximately $23,000,000 in our
outpatient rehabilitation business, primarily
attributable to the impact of Transmittal1753, and an additional $34,000,000 decrease
in revenues in our outpatient rehabilitation
business attributable to a decline in patient
volumes . We also saw an increase of about
$39,000,000 in operating unit expenses ascompared to the second quarter, primarily
attributable to field training for therapists
in the new Medicare policy, increased
recruiting and labor costs, higher insurancepremiums and new market initiatives aimed at
restoring patient volumes .
168 . HealthSouth provided further particulars in the Thir d
Quarter 10-Q on the extent to which the Company's bottom line had
been adversely affected : net income for the quarter had declined
to $53,614,000, from $79,126,000 for the third quarter of 2001 .
And, net income for the first nine months of 2002 was basicall y
1730 / CMP / 00060147.WPD vi 7 1
flat with the results reported the prior year : $135,704,000 a s
compared to $134,489,000 the prior year .
169 . On November 26, 2002, HealthSouth announced that i t
will be reducing its workforce by up to 2% as part of a Company-
wide cost-cutting response to the impact of Transmittal 1753,
i .e ., complying with Medicare's long-standing group therapy
billing requirements . Defendant Scrushy explained the layoffs as
needed "to respond to the current dynamics of our business . "
The Government Commences a Criminal Investigation
170 . On February 6, 2003, HealthSouth issued a press releas e
announcing that it had received a subpoena from the United States
Attorney's Office for the Northern District of Alabama seeking
production of various documents . The Company further stated that
"the types of documents requested suggest that the investigation
may focus on transactions by individuals in HealthSouth common
stock . "
171 . That same day the Federal Bureau of Investigation (th e
"FBI") confirmed that it had opened a criminal investigation into
"possible securities laws violations" at the Company . The FBI
spokesman further said that the FBI had conducted a series of
interviews of HealthSouth executives over the prior two days in
connection with the investigation, but declined to disclose any
particulars . The Wall Street Journal reported in its February
10, 2003 edition that William Horton, HealthSouth Executive Vice
President and Corporate Counsel, had stated that the FBI ha d
1730 / CMP / 00060147 .WPD vl 72
questioned approximately 10 current or former employees who had
traded HealthSouth shares last summer . According to the Journal,
Mr . Horton declined to identify the individuals, but stated that
they were not senior executives .
The Company Reports a Staggering
Loss for the Fourth Quarter and Yea r
172 . On March 3, 2003, HealthSouth issued a press release
(the "March 3 Press Release" ) reporting that the Company had lost
$405,800,000 for the fourth quarter of 2002 and $202,400,000 for
the year . In that Press Release, defendants summarized
HealthSouth's abysmal performance as follows :
For the 2002 quarter, the company incurred a
net loss of ($405 .8) million, compared to net
income for the 2001 quarter of $67 .9 million .Operating income for the 2002 quarter was
$18 .6 million, compared to operating incomeof $88 .6 million for the 2001 quarter . The
company incurred a net loss per share
(assuming dilution) of ($1 .03) for the 2002quarter, compared to earnings per share
(assuming dilution) for the 2001 quarter of
$0 .17 . Operating earnings per share(assuming dilution) were $0 .05 for the 2002quarter, compared to $0 .22 for the 2001
quarter . . . .
The company incurred a net loss of ($270 .1)million for 2002, compared to net income for
2001 of $202 .4 million . Operating income for2002 was $267 .3 million, compared tooperating income of $326 .1 million for 2001 .
For the year, the company incurred a net lossper share (assuming dilution) of ($0 .68),
compared to earnings per share (assumingdilution) of $0 .51 for 2001 . Operating
earnings per share (assuming dilution) for2002 were $0 .67, compared to $0 .82 for 2001 .
1730 / CMP / 00060147.WPD vi 73
173 . Consequently, HealthSouth operated at a massive loss
for 2002, not the $1 .14 per share profit defendants had
repeatedly represented during the Class Period (e .g ., 11 104-113
and 121, supra) would be earned . And, although defendants
attempted in the March 3 Press Release to obscure the causes of
the losses, a material portion of the staggering losses was
caused by the reduced revenues and profits and increased expenses
occasioned by the Company's belated efforts to comply with the
Government's long-standing Medicare billing requirements ; the
need to retrain HealthSouth employees to comply with those
Government mandates ; the legal fees incurred and reserves
established to respond to the claims asserted by the Government
and the relators in the aui tam actions ; and the costs associated
with the SEC and FBI investigations . As described in the March 3
Press Release, these charges included :
Restructuring charges of approximately $255 .5million ($175 .7 million net of taxes)relating to the company's decision to close,consolidate or sell approximately 220facilities, primarily outpatientrehabilitation facilities . This decision wasmade primarily in response to the impact ofdecreased Medicare reimbursement foroutpatient rehabilitation services . . . .
Asset impairment charges . . . of approximately$55 .6 million ($34 .1 million net of taxes) .The impairment charges . . . primarily relateto the adverse impact of decreases inMedicare reimbursement for outpatientrehabilitation services .
Goodwill impairment charges . . . ofapproximately $80 .5 million ($62 .5 millionnet of taxes ) . . . . Again, the impairment isprimarily related to diminished expecte d
1730 / CMP / 00060147.WPD v1 7 4
future cash flows primarily relating to theadverse impact of decreases in Medicarereimbursement for outpatient rehabilitation
services . . . .
Other Unusual Charges : In addition to the
amounts described above as "Restructuring and
Other Charges ", during the fourth quarter the
company incurred certain additional unusual
charges , the effects of which are reflected
in other line items on the company's income
statement . These items aggregated
approximately $194 .8 million ($119 .3 net of
taxes ) . The cash portion of such charges was
approximately $175 .8 million ($107 .7 million
net of taxes ) . Those items include the
following :
The company ' s results of operations includethe effects of a change in estimate relatingto the valuation of accounts receivable andbad debt expense as a result of a detailedanalysis of the collectibility of accountsreceivable . . . . The results of this change inestimate are reflected as a reduction ofapproximately $100 .0 million ($61 .3 millionnet of taxes) in revenues and an increase ofapproximately $10 .0 million ($6 .1 million netof taxes ) in bad debt reserves .
In addition to the foregoing, the companyincurred significant expenses in the fourth
quarter relating to legal, consulting and
audit fees incurred in connection with the
proposed tax-free separation of the company'ssurgery center operations and legal,
consulting and other professional feesrelating to litigation, internal and external
investigations and related matters .
Emphasis added .
174 . Also on March 3, HealthSouth hosted a conference cal l
for investors and securities analysts during which Defendants
Scrushy and Owens were the principal Company spokespersons .
Defendant Scrushy began the presentation "by stating that 2002
1730 / CMP / 00060147 .WPD vl 7 5
was a very difficult year for our company . . . due to Transmittal
1753 . . . .' He and Defendant Owens then provided further
financial and other particulars on the fourth quarter charges and
losses, including the costs and disruption of retraining Company
personnel and otherwise complying with the Government's Medicare
billing requirements ; and the $6 million "substantial expense for
attorneys, consultants related to the litigation and the SEC
investigation ." In response to an inquiry from a participant,
Scrushy also disclosed that over the next few weeks the Company's
senior management will be questioned by the SEC in connection
with its investigation .
SCIENTER
175 . Numerous facts confirm that Defendants had actua l
knowledge of the misrepresentations and materially incomplete
statements of material facts set forth herein, or acted with
reckless disregard for the truth in that they failed to ascertain
and to disclose such facts, even though such facts were availabl e
to them .
176 . First, the applicable Government rules and regulations
governing the appropriate method of billing for group therapy
sessions had been in effect since 1994 and had been repeatedly
restated in both Government and industry periodicals (see 19[ 31-
48, supra) .
177 . Second, as detailed in paragraphs 49-75, supra, the
Company received extensive internal communications from numerous
1730 / CMP / 00060147.WPD v1 7 6
employees over a period of years questioning, among other
improper actions, the Company's practice of upcoding and the fact
that the Company's computer claims program did not even allow
coding for group therapy . Instead of appropriately addressing
these issues, Defendants chose to "stonewall" the inquiries in
order artificially to boost the Company's revenues, earnings, and
stock price .
178 . Third, the complaints filed in the qui tam actions by
former patients and a former employee against HealthSouth (11 76-
101, supra) provided considerable detail demonstrating that
HealthSouth's billing practices were improper and that,
accordingly, its revenues and income were being overstated .
These disclosures and the Government's Complaint in intervention
in the Devage Action were ignored as well .
179 . Fourth, the extensive audit of numerous HealthSout h
facilities by Cahaba on behalf of the Government (a% 82-91,
supra) revealed numerous improprieties in HealthSouth's billing
practices and procedures, including substantial upcoding ; billing
by unqualified personnel ; and billing for services not performed .
These extensive improprieties were ignored as well by Defendants .
180 . Fifth, Defendant Scrushy and HealthSouth director
Strong (personally and through trusts he had established)
collectively sold or disposed of about $101 million worth of
HealthSouth stock at prices ranging from $10 .06 per share to
$14 .05 per share . These sales and the disposition were unusual
in both timing and amount, far exceeding the insiders' previous
1730 / CMP / 00060147 .WPD v1 77
sales . The following chart details the insiders' sales durin g
the Class Period :
INSIDER SALES DURING THE CLASS PERIOD
Price
Transaction # of Per
Filer ' s Name Date Description Shares Share Proceeds
Scrushy, Richard 5/14/02 Sale 5,275,360 $14 .05 $ 74,118,80 8
Scrushy, Richard 7/31/02 Disposition 2,506,770 10 .06 25,218,10 6
Strong, George 2/13/02 Sale 7,000 12 .26 85,82 0
Strong, George 2/14/02 Sale 445 12 .27 5,46 0
Sale 2,100 12 .28 25,78 8
Sale 14,300 12 .26 175,31 8Sale 16,000 12 .26 196,16 0
Strong, George 2/15/02 Sale 6,680 11 .90 79,49 2
Strong, George 6/7/02 Sale 52,125 13 .78 718,54 8
Strong, George 6/11/02 Sale 17,216 14 .28 245,84 4
TOTALS 7,897,996 $100,869,34 4
181 . Finally, the Company' s statements in response to the
disclosures concerning the SEC and FBI investigations into the
insider trading involving HealthSouth strongly suggest that there
were other sales by HealthSouth executives, employees or insiders
that have not yet been publicly disclosed ( 51 162-63 and 170-71,
supra) . All of the foregoing facts support the conclusion that
Defendants acted knowingly or recklessly in committing the
wrongful acts alleged herein .
NO SAFE HARBOR
182 . The statutory safe harbor provided for forward-looking
statements under certain circumstances does not apply to any o f
1730 / CMP / 00060197.WPD vi 7 8
the allegedly false statements pleaded in this Complaint . The
statements alleged to be false and misleading herein all relate
to then-existing facts and conditions . In addition, to the
extent certain of the statements alleged to be false may be
characterized as forward looking, they were not identified as
"forward-looking statements" when made, there was no statement
made with respect to any of those representations forming the
basis of this Complaint that actual results "could differ
materially from those projected," and/or there were no meaningful
cautionary statements identifying important factors that could
cause actual results to differ materially from those in the
purportedly forward-looking statements . In the alternative, to
the extent that the statutory safe harbor is intended to apply to
any forward-looking statements pleaded herein, Defendants are
liable for those false forward-looking statements because at the
time each of those forward-looking statements was made, the
speaker had actual knowledge that the forward-looking statement
was materially false or misleading, and/or the forward-looking
statement was authorized or approved by an executive officer of
HealthSouth who knew that the statement was false or misleading
when made .
1730 / CMP / 00060147 .WPD v1 79
FIRST CLAIM FOR RELIEF
For Violations of Section 10(b) of the ExchangeAct and SEC Rule 10b-5 Promulgated Thereunder
( Against All Defendants )
183 . Plaintiffs repeat and reallege each and every
allegation contained above, as if fully set forth herein .
184 . During the Class Period, Defendants carried out a plan ,
scheme and course of conduct which was intended to and did :
(i) deceive the investing public, including Plaintiffs and other
Class members, as alleged herein ; (ii) artificially inflate and
maintain the market price of HealthSouth shares ; and (iii) cause
Plaintiffs and other members of the Class to purchase HealthSouth
shares at artificially inflated prices . In furtherance of this
unlawful scheme, plan and course of conduct, Defendants, and each
of them, took the actions set forth herein .
185 . Defendants (a) employed devices, schemes, and artifice s
to defraud ; (b) made untrue statements of material fact and/or
omitted to state material facts necessary to make the statements
made not misleading ; and (c) engaged in acts, practices, and a
course of business which operated as a fraud and deceit upon the
purchasers of HealthSouth shares in violation of Section 10(b) of
the Exchange Act and Rule 10b-5 . All Defendants are sued as
primary participants in the wrongful and illegal conduct charged
herein .
186 . In addition to the duties of full disclosure imposed on
Defendants as a result of their making of affirmative statement s
1730 / CMP / 00060147 .WPD v1 8 0
and reports, or participation in the making of affirmative
statements and reports to the investing public, Defendants had a
duty to promptly disseminate truthful information that would be
material to investors in compliance with the integrated
disclosure provisions of the SEC as embodied in SEC Regulation S-
X (17 C .F .R . Sections 210 .01 et seq .) and Regulation S-K (17
C .F .R . Sections 229 .10 et seq.) and other SEC regulations,
including accurate and truthful information with respect to the
Company's operations, financial condition and earnings, so that
the market price of HealthSouth's shares would be based on
truthful, complete and accurate information .
187 . Defendants , individually and in concert, engaged and
participated in a continuous course of conduct to misstate and
conceal adverse material information about the business,
operations and future prospects of HealthSouth as specified
herein .
188 . The Individual Defendants' primary liability, and
controlling person liability, arises from the following facts :
(i) these Defendants were high-level executives and/or directors
at the Company throughout the Class Period ; (ii) Defendants were
privy to and participated in the creation, development and
reporting of the Company's internal budgets, plans, projections
and/or reports ; (iii) Defendants directed the Company's
dissemination of information to the investing public, which
information they knew or recklessly disregarded was materially
false and misleading ; and (iv) Defendants personally mad e
1730 / CMP / 00060147 .WPD vl 81
materially false and misleading statements to the financial
community .
189 . During the Class Period, Defendants materially misle d
the investing public, thereby inflating the price of HealthSouth
shares, by publicly issuing false and misleading statements and
omitting to disclose material facts necessary to make Defendants'
statements, as set forth herein, not false and misleading . Said
statements and omissions were materially false and misleading in
that they failed to disclose material adverse information and
misrepresented the truth about the Company, its business and
operations, including, the adverse facts alleged herein .
190 . The material misrepresentations and materiall y
incomplete statements particularized in this Complaint directly
or proximately caused or were a substantial contributing cause of
the damages sustained by Plaintiffs and other members of the
Class . As described herein, during the Class Period, Defendants
made or caused to be made a series of materially false or
misleading statements about HealthSouth's business, prospects and
operations . These material misstatements and materially
incomplete statements had the cause and effect of creating in the
market an unrealistically positive assessment of HealthSouth and
its business, prospects and operations, thus causing the
Company's shares to be overvalued and artificially inflated
throughout the Class Period . Defendants' materially false and
misleading statements during the Class Period resulted in
Plaintiffs and other members of the Class purchasing HealthSout h
1730 / CMP / 00060147 . WPD vl 82
shares at artificially inflated prices, thus causing the damages
complained of herein .
191 . Defendants had actual knowledge of the
misrepresentations and materially incomplete statements of
material facts set forth herein, or acted with reckless disregard
for the truth in that they failed to ascertain and to disclose
such facts, even though such facts were available to them . The
material misrepresentations and/or materially incomplete
statements were made knowingly or recklessly and for the purpose
and effect of concealing HealthSouth's operating condition and
future business prospects from the investing public and
supporting the artificially inflated price of HealthSouth shares .
192 . Plaintiffs and the other members of the Class purchased
HealthSouth shares during the Class Period in ignorance of the
fact that the prices of shares were artificially inflated, and
relied directly or indirectly on the false and misleading
statements made by Defendants, or upon the integrity of the
market in which the shares trade, and/or upon the absence of
material adverse information that was known to or recklessly
disregarded by Defendants but not disclosed in public statement s
by Defendants during the Class Period .
193 . At the time of said misrepresentations and omissions ,
Plaintiffs and other members of the Class were ignorant of their
falsity, and believed them to be true . Had Plaintiffs and the
other members of the Class and the marketplace known of the true
financial condition and business prospects of HealthSouth, which
were not disclosed by Defendants, Plaintiffs and other members of
1730 / CMP / 00060147 .WPD vl 8 3
the Class would not have purchased their HealthSouth shares, or,
if they had purchased such securities during the Class Period,
they would not have done so at the artificially inflated prices
that were paid .
194 . By virtue of the foregoing, Defendants have violated
Section 10(b) of the Exchange Act, and SEC Rule lob-5 promulgated
thereunder .
195 . As a direct and proximate result of Defendants'
wrongful conduct, Plaintiffs and the other members of the Class
suffered damages in an amount to be proved at trial .
SECOND CLAIM FOR RELIEF
For Violations of Sections 20(a ) of The Exchange Act
( Against the Individual Defendants )
196 . Plaintiffs repeat and reallege each of the precedin g
paragraphs as if fully set forth herein .
197 . This claim is brought against each of the individua l
Defendants .
198 . Each of the Individual Defendants was a control perso n
of HealthSouth within the meaning of Section 20(a) of the
Exchange Act .
199 . By virtue of his high-level positions described herein,
and his participation in and/or awareness of the Company's
operations and/or intimate knowledge of the statements filed by
the Company with the SEC and disseminated to the investing
public, each of the Individual Defendants had the power t o
1730 / CMP / 00060147 .WPD vl 84
influence and control and did influence and control, directly or
indirectly, the decision-making of the Company, including the
content and dissemination of the various statements that were
materially false and misleading . Further, each of the Individual
Defendants was provided with or had unlimited access to copies of
the Company's reports, press releases, public filings and other
statements alleged by Defendants to be misleading prior to and/or
shortly after these statements were issued and had the ability to
prevent the issuance of the statements or cause the statements to
be corrected .
200 . As set forth above, Defendants violated Section 10(b )
of the Exchange Act, and Rule lob-5 promulgated thereunder, by
their acts and omissions as alleged in this Complaint . By virtue
of their positions as control persons, each of the Individual
Defendants is also liable to Defendants and the Class pursuant to
Section 20(a) of the Exchange Act .
201 . As a direct and proximate result of the Individual
Defendants' wrongful conduct, Plaintiffs and the Class suffered
damages in connection with their purchases of Company shares
during the Class Period in an amount to be proved at trial .
PRAYER FOR RELIEF
WHEREFORE , Plaintiffs, on behalf of themselves and all other
Class members , pray for judgment as follows :
1730 / CMP / 00060147 .WPD v1 85
A . Determining that this action is a proper class action
and certifying the Class under Rule 23 of the Federal Rules of
Civil Procedure ;
B . Awarding compensatory damages in favor of Plaintiffs
and the other Class members against all Defendants for damages
sustained as a result of Defendants' wrongdoing, together with
interest thereon ;
C . Awarding Plaintiffs and the Class their reasonable
costs and expenses incurred in this action, including counsel
fees, expert fees and other disbursements ; and
D . Granting Plaintiffs and the Class such other and
further relief as the Court may deem just and proper .
JURY TRIAL DEMANDED
Plaintiffs hereby demand a trial by j y .
Dated : March 12, 2003
Respectfullyi Xu4nitted ,
Joe R . WhaVl k-ly , Jr . (WHAO03)
Russell Jackson Drake (DRA008)G . Douglas Jones (JON012)
Othni J . Lathram (LAT016)WHATLEY DRAKE, LL CP .O . Box 1064 7Birmingham, AL 35202-0647Tel : 205-328-957 6Fax : 205-328-966 9
Liaison Counsel on behalf of theLead Plaintiffs and the ProposedClas s
1730 / CMP / 00060147 .WPD v1 8 6
Neil L . SelingerRichard BemporadLOWEY DANNENBERG BEMPORAD
& SELINGER, P .C .
The Gateway-11th FloorOne North Lexington AvenueWhite Plains, NY 10601-1714Tel : 914-997-050 0Fax : 914-997-0035
Lead Counsel on behalf of theLead Plaintiffs and the ProposedClass
1730 / CMP / 00060147.WPD v1 87
A
CERTIFICATE OF SERVICE
I hereby certify that I have served a copy of the above an d
foregoing pleading on the following counsel of record by
depositing same in the U . S . Mail, postage prepaid on thi s
day of March, 2003 .
J . Michael Rediker
Thomas L . Krebs
Patricia C . Diak
Michael K . K . Choy
HASKELL, SLAUGHTER, YOUNG & REDIKER, LLC
1901 Sixth Avenue Nort h
Suite 1200 AmSouth/Harbert Plaza
Birmingham, AL 354203-261 8
N . Lee Cooper
Patrick C . Cooper
Scott S . Brown
MAYNARD, COOPER & GALE, P .C .
1901 Sixth Avenue North
2400 AmSouth/Harbert Plaza
Birmingham, AL 35203-260 2
Peter Q . Bassett
Susan E . Hurd
ALSTON & BIRD, LL P
1201 West Peachtree StreetAtlanta, GA 30309-342 4
Lanny J . Davis
PATTON BOGGS LLP
2550 M Street, NW
Washington, DC 20037
ADDITIONAL COUNSEL FOR PLAINTIFFS
Mark G . Gardy, Esq .
Nancy Kaboolian, Esq .
Abbey Gardy, LLP
212 East 39th StreetNew York, NY 10016
Tel : 212-889-3700
Fax : 212-684-5191
James V . Bashian, Esq .
Law Offices of James V .
Bashian, P .C .
500 Fifth Avenue, Ste . 2700New York, NY 10110Tel : 212-921-4110Fax : 212-921-424 9
Douglas M . McKiege, Esq .
Bernstein Litowitz Berger
& Grossman, LLP1285 Avenue of the AmericasNew York, NY 1001 9Tel : 212-554-1400Fax : 212-554-144 4
John L . Chalif, Esq .
The Galleria International Bldg
301 Clematis Street, Ste . 3000
West Palm Beach, FL 3340 1
Tel : 561-820-9488Fax : 561-366-111 6
Martin Chitwood, Esq .
Chitwood & Harley1230 Peachtree Street, NE
Promenade II, Ste . 2900
Atlanta, GA 3030 9
Tel : 404-873-3900Fax : 404-876-447 6
Steven J . Toll, Esq .
Cohen, Milstein, Hausfeld
& Toll, P .L .L .C .1100 New York Avenue,
West Tower, Ste . 500
Washington, DC 20005Tel : 202-408-4600
Fax : 202-408-4699
David J . Guin, Esq .
Donaldson & Guin, Esq .
2 North 20th Street, Ste . 1100
Birmingham, AL 3520 3
Tel : 205-226-2282
Fax : 205-226-2357
John G . Emerson, Jr ., Esq .
Emerson Poynter LL P
P .O . Box 16481 0Little Rock, AR 72216-4810
Tel : 501-907-255 5
Fax : 501-907-255 6
Andrew J . Entwistle, Esq .
Entwistle & Cappucci LLP
299 Park Avenue, 14th Fl .
New York, NY 1017 1
Tel : 212-894-7207Fax : 212-894-727 2
Nadeem Faruqi, Esq .
Faruqi & Faruqi
320 East 39th Street
New York, NY 10016
Tel : 212-983-9330
Fax : 212-983-933 1
Richard R . Rosenthal, Esq .
Garrison, Scott, Gamble & Rosenthal
2224 1st Avenue North
Birmingham, AL 35203Tel : 205-326-3336Fax : 205-326-333 2
Ira M . Press, Esq .
Kirby, McInerney & Squire
830 3rd Avenue
New York, NY 10022
Tel : 212-371-6600
Fax : 212-751-254 0
N .W. John Halebian, Esq .Lovell Stewart Halebian, LLP
500 Fifth Avenue, Ste . 5800
New York, NY 1011 0
Tel : 212-608-1900
Fax : 212-719-467 7
1730 / MISC / 00060351 .WPD v1 8 8
Mark McNair, Esq .
Law offices of mark McNair1101 30th Street, NW, Ste . 500Washington , DC 20007Tel : 877-511-4717Fax : 202 -872-4718
Michael C . Spencer, Esq .
Carlos F . Ramirez, Esq .
Milberg, Weiss, Bershad,
Hynes & Lerach
One Pennsylvania PlazaNew York, NY 10119
Tel : 212-594-5300
Fax : 212-868-122 9
James L . North Esq .James L . North & Associates
Title Building, Ste . 700
300 N . 21st StreetBirmingham, AL 3520 3
Tel : 205-251-0252Fax : 205-251-025 5
Charles J . Piven, Esq .Law Offices of Charles J . PivenWorld Trade Center-Baltimore401 East Pratt Street, Ste . 2525Baltimore, MA 2120 2Tel : 410-986-0036
Fax : 410-685-1300
M . Clay Ragsdale, Esq .Law Offices of M . Clay Ragsdale
1929 3rd Avenue North, Ste . 550Birmingham, AL 3520 3Tel : 205-251-4775
Fax : 205-251-477 7
Andrew M . Schatz, Esq .
Schatz & Nobel, P .C .
330 Main Street, 2nd FloorHartford, CT 0610 6Tel : 860-493-6292Fax : 860-493-6290
Jules Brody, Esq .
Stull, Stull & Brody6 East 45th Street
New York, NY 10017
Tel : 212-687-7230
Fax : 212-490-2022
Robert Roden, Esq .Shelby, Roden & Cartee, LLC
2956 Rhodes CircleBirmingham, AL 3520 5Tel : 205-933-8383
Fax : 205-933-2299
Curtis V . Trinko, Esq .
Law Offices of Curtis V . Trinko16 West 46th Stree t
New York, NY 10036Tel : 212-490-9550Fax : 212-986-015 8
Robert I . Harwood, Esq .Wechsler Harwood, LLP
488 Madison Avenu e
New York, NY 10022Tel : 212-935-7400Fax : 212-753-363 0
Joseph H . Weiss, Esq .
Weiss & Yourman
551 Fifth AvenueNew York, NY 10176Tel : 212-682-3025Fax : 212-682-301 0
Fred T . Isquith, Esq .
Wolf Haldenstein Adler Freeman& Herz
270 Madison Avenue
New York, NY 10016Tel : 212-545-4600
Fax : 212-686-011 4
1730 / MISC / 00060351 .WPD v1 8 9
SCHEDULE 1
1 . Smith, et al . v . HealthSouth, et al . , CV-02-BE-2105-2
2 . Epstein, et al . v . HealthSouth, et al . , CV-02-C-2147-W
3 . Epps, et al . v . HealthSouth, et al . , CV-02-JEO-2161 S
4 . Pollock, et al . v . HealthSouth, et al . , CV-02-BE-2175-W
5 . Burke, et al . v . HealthSouth, et al . , CV-02-BE-2178-S
6 . Stark, et al . v . HealthSouth, et al . , CV-02-AR-2193-S
7 . Strauss, et al . v . HealthSouth, et al . , CV-02-Be-2194-S
8 . Mizzaro, et al . v . HealthSouth, et al . , CV-02-BE-2195-S
9 . Herman, et al . v . HealthSouth, et al . , CV-02-S-2232-S
10 . Minker, et al . v . HealthSouth, et al . , CV-02-TMP-2252-S
11 . Klein, et al . v . HealthSouth, et al . , CV-02-PNPG-2259-5
12 . Bower, et al . v . HealthSouth, et al . , CV-02-N-2264-S
13 . White, et al . v . HealthSouth, et al . , CV-02-S-2309-S
14 . Gerstle, et al . v . HealthSouth, et al . , CV-02-S-2349- S
1730 / MISC / 00060352 .WPD v1
SCHEDULE 2
1 . The Louisiana Municipal Police Employees' Retirement
System
2 . Bunny Davis Ayers
3 . Michael T . Burke
4 . Cecil Duke
5 . V.E . Epps as Trustee for the Ed Epps Trust
6 . Mark G . Epstein
7 . John Mizzaro
8 . John G . Snelling
9 . Gail Lynn Stark
10 . David R . Vial
1730 / MISC / 00060352 .WPD vl